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CHAPTER 1. INTRODUCTION 
Everyday life presents considerable challenges for people living with epilepsy. 
Epilepsy self-management includes a broad range of daily health behaviors that afflicted 
persons use to help mitigate their seizures and inform clinical decision-making [1]. Many 
patients and caregivers struggle to adopt these behaviors due to the burden of data 
collection and reporting. New mobile health or mHealth sensing and data input 
capabilities could provide opportunities for facilitating aspects of these patient and 
caregiver data collection needs, which in turn could better inform clinical decision 
making and patient self-reflection within the context of self-management. 
My research is grounded in the fields of Human and Computer Interaction (HCI) and 
health informatics and investigates the role that mobile and wearable computing devices 
can play for supporting epilepsy self-management. 
The inspiration for this work has stemmed from my first-hand experiences working with 
patients, caregivers and clinicians at the Children’s Healthcare of Atlanta (CHOA) and 
Emory University Hospital (EUH). I began interviewing caregivers and clinicians to 
establish technical requirements for wearable seizure detection devices. In the process, I 
discovered an even stronger need for more supportive, comprehensive, family-based data 
collection tools. My focus gradually shifted towards investigating methods and strategies 
for encouraging consistent and prompt daily self-reporting. In this thesis, I will present 
the design, development, and evaluation of pediatric epilepsy self-management tools and 
interventions that I developed for supporting patients, caregivers, and clinicians.  
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My thesis statement is as follows: 
Epilepsy self-management can be improved through the introduction of mobile and 
wearable interventions that enable adolescent patients and family members to 
collect the types and characteristics of data that clinicians need during epilepsy 
diagnosis and treatment, respectively, and also increase patient engagement - an 
indicator of successful, future self-management in preparation for adult self-care. 
My research findings have since helped to address the following knowledge gaps within 
HCI and health informatics: 
1. Establishing data collection needs during epilepsy treatment - There is a need to 
clarify technical aspects of data collection requirements for developing mobile and 
wearable data collection tools. My results established clinician, patient and caregiver 
needs as a first step in determining how to best balance tradeoffs between active and 
passive data collection between clinical appointments. 
2. Investigating new methods and strategies for improving data collection quality - 
There is a need to improve data collection quality for addressing patient, caregiver, 
and clinician information needs. My results established the performance of wearable 
seizure detection devices and evaluated the feasibility of using mobile phone surveys 
and health tracking tools for consistent, prompt and reliable data collection. 
3. Evaluating the impact of these methods and strategies on patient engagement - 
There is a need to evaluate the impact of data collection tools on patient health 
outcomes. My results showed that daily mobile phone surveys can have a positive 
impact on patient engagement as an important factor for successful long-term patient 
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self-management outcomes [2], [3]. 
In this thesis, I will present my findings from five research studies. I describe each set of 
findings in terms of both clinical applications for supporting patient care and technical 
implications for informing the design of pediatric mobile and wearable tools for 
supporting epilepsy self-management practices. 
The remainder of this thesis is structured as follows: I present background information on 
epilepsy, describe motivating related work, discuss my research studies, my findings and 





CHAPTER 2. BACKGROUND 
2.1 Epilepsy self-management 
2.1.1 New challenges for everyday computing 
Epilepsy is a neurological condition characterized by recurrent, unprovoked seizures [4]. 
Fifty million people are impacted by epilepsy worldwide [5]. In the United States, “1 in 
26” people will be diagnosed with epilepsy [6] at an estimated cost of $12.5 billion [7]. 
Epilepsy is the fourth most common neurological disorder after migraine, stroke and 
Alzheimer's disease [8].  
Most patients can significantly reduce the risk of seizures by taking daily medications 
and making lifestyle changes [3]. Medications known as antiepileptic drugs (AED) have 
been shown to be effective for 60-80% of patients [4], [9]–[12]. In addition, patients can 
often “self-manage” sleep, mood, exercise and other behaviors to further reduce the risk 
of seizures and increase quality of life (QoL) [2]. 
Epilepsy self-management refers to a range of practices for addressing the impact of 
seizures on daily life. These practices are recommended as a part of treatment and 
typically include: 1) taking seizure control medications [13], 2) informing health care 
providers by documenting seizures and their contributing behaviors [14], [15] such as 
sleep [16], [17], and exercise [18], [19], and 3) learning to self-regulate behaviors for 
managing symptoms [3]. The current standard of care is for patients and caregivers to 
maintain a “seizure diary” for logging the date, time and a description of seizure events. 
In addition, patients and caregivers are often asked to observe and document a wide range 
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of additional health-related events and behaviors between appointments such as seizure 
counts, sleep duration, physical activity, stressful events and life changes, alcohol use, 
food intake, menstruation-cycles  and medication adherence [20], [21]. 
In practice, patients and caregivers struggle with the data collection aspects of these 
epilepsy self-management practices for a range of reasons. Lifestyle changes such as 
sleep and stress can be difficult to implement due to pressures of work and school.  
Many patients see these tasks as a daily burden [22]. Social stigma [23] can discourage 
patients from taking medications while at school. Night time seizure reporting can 
present particular challenges. Most patients are unable to report seizures during sleep 
(>85%) and 32% of the patients fail to report seizures while awake [24]. Memory and 
cognitive impairments are also prevalent among patients with epilepsy [25]–[27]. Patients 
may be unconscious and unable to recall details during or following seizure events [28]. 
Similarly, many caregivers also struggle with patient data collection. Studies have shown 
that caregivers often disagree on important seizure characteristics [29]. Logistics and 
record keeping [30] issues such as collecting seizure reports from school can be difficult 
for caregivers to keep up with. Caregivers may not be awake to report patient seizures at 
night [31]. In practice, families at CHOA and Emory tend to discontinue seizure diaries 
shortly after diagnosis (0.5 - 2 months).  
Health tracking devices (or tools/technologies) stand to support data collection but 
currently provide mixed performance relative to patient-self-reporting. For example, 
Fitbit exercise and sleep reports have been shown to agree well with patient self-reports 
of these behaviors [32] while the SmartWatch and similar seizure detection devices tend 
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to over-report seizure events when compared with patient and clinical observations [33]. 
These daily self-reporting and self-management barriers present two sets of problems. 
First, patients with poor self-management skills also tend to have poor seizure control. 
Living with poorly controlled seizures can be highly stressful for patients and caregivers 
[34]. High rates of seizures are shown to be associated with greater unemployment [35], 
depression [35], [36], cognitive decline [37] and increased mortality rates [38]. Second, 
inaccurate or incomplete self-reporting can negatively impact treatment. Newly 
diagnosed patients try an average of two AEDs before finding one that is both effective 
and tolerable [39] (ideally the goal is for patients to be on as few medications as possible 
to control seizures). This AED search can take 6-12 months [40] during which time 
patients often experience debilitating medication side-effects. Neurologists at CHOA 
typically see patients every 6 weeks while adjusting medications, and every 6 months 
after an effective medication is found. Medication dosages may require further 
adjustment over the course of treatment to remain effective. In turn, poor self-reporting 
can prolong the AED search process, resulting in patients being exposed to medication 
side-effects for longer than necessary, and similarly increase the difficulty of making 
medication adjustments, resulting in patients continuing to have seizures that may 
otherwise be addressed with a change in dosage or treatment. 
Everyday computing and mobile and wearable technologies stand to help address these 
self-management challenges but solutions in this area are not well explored. 
Electroencephalogram (EEG) and video (vEEG) equipment are currently used to provide 
clinicians with accurate seizure reporting during 2-5 day hospital visits, but these tools 
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require patients to wear EEG electrodes on the scalp at all times, restrict patient 
movement and require input from trained technicians to interpret results [41]. EEG 
electrodes can be connected to patient-worn ambulatory EEG (AEEG) recording 
computers for extended monitoring outside of the clinic; however, these systems present 
a host of problems such as noisy or missing EEG readings due to loose electrode 
connections and often do not include video cameras for observing important clinical 
seizure symptoms. Non-EEG seizure detection devices have been proposed [33]; 
however, these devices tend to report high numbers of false alarms and are subsequently 
less useful for supporting clinical decision making [42]. Health Insurance Portability and 
Accountability Act (HIPPA) compliant data collection services are expensive and have 
limited flexibility for research studies. Health tracking technologies for fitness and 
activity tracking have not yet been adapted to reflect patient behavioral factors that 
impact seizure likelihood such as sleep and exercise. Meanwhile, prospective technology 
developers currently lack basic design guidelines for specifying patient data collection 
and self-management requirements [43]. It is, therefore, important for researchers to 
investigate new mobile and health tracking approaches for addressing current 
shortcomings and providing patients and caregivers with more effective and convenient 
data capture, access, summarization, and interpretation. 
My research has responded to these needs by first establishing patient, caregiver and 
clinical data collection needs and then developing and evaluating new mobile and 
wearable data collection tools to answer unexplored HCI and health informatics research 
questions. In contrast to a more traditional, siloed research agenda such as signal analysis 
for seizure detection [44], my goal was to understand and address broader social and 
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technical challenges that arise when mobile and wearable data collection tools are 
introduced into a patient’s everyday environments. 
2.1.2 Supporting adolescent patients 
My studies share a common focus on investigating and supporting family self-reporting 
within the context of pediatric self-management. In contrast to previous researchers, my 
studies focus on three needs that are critical to consider when designing for pediatric 
patients but have received less attention when designing for adults: 
1. Self-regulating patient behaviors - Notable risks associated with poor self-
management include poor seizure control that can lead to serious seizure-related 
injuries [45] and death [46], [47] negative personal and family financial repercussions 
[7], [48] and embarrassing social consequences such as incontinence in public [49]. In 
addition, having epilepsy is known to reduce the Quality of Life (QOL) [49] for both 
patients and caregivers [34], [50]. Many patients and caregivers already maintain 
seizure diaries that document seizures, sleep [16], exercise [18] and other behavioral 
factors with the goal of adopting behaviors that reduce the likelihood of seizures. It is 
important to better understand these needs and investigate the extent that technologies 
can encourage reviewing behaviors and staying within recommended behavior 
guidelines on a daily basis. 
2. Self-reporting during treatment - Neurologists rely almost exclusively on patient 
self-reporting to adjust medications during treatment [33]; however, patients and 
caregivers rarely keep detailed records. This issue is especially problematic within 
epilepsy as roughly half of all newly diagnosed patients with epilepsy (53% of 
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patients) require trying one or more AEDs before finding one that can control 
seizures [39]. The process of finding an effective drug can take months or even years, 
during which time patients often experience debilitating side effects. It is, therefore, 
important to understand clinical information needs from the perspective of data 
quality requirements and to investigate ways that technologies can help collect health 
data that is meaningful for informing clinical treatment [51]. 
3. Increasing self-reliance for adult care - Many adolescent patients with epilepsy fail 
to achieve a smooth transition between pediatric and adult self-care with higher than 
usual numbers of seizure events and missed appointments [52]. Help and support 
from caregivers such as reminders to take medication and regulate behaviors such as 
sleep and exercise may become increasingly impractical as adolescents become more 
independent. Moreover, adolescent patients are often faced with additional peer 
pressure to engage in drinking, drugs and other behaviors that can contribute to 
increasing the likelihood of having seizures during this time [29]. It is, therefore, 
important to investigate the extent that technologies can help to engage pediatric 
patients in preparation for leaving home for college, and eventually adult self-care. In 
addition, such tools stand to further ease this transition by including caregivers in this 
process as needed until patients are able to master self-management skills. 
I, therefore, argue that there is a strong need for further research aimed at addressing 
underexplored gaps within this body of literature. My studies have addressed aspects of 




The research study team included collaborators from Georgia Tech, Emory University, 
CHOA and Empatica Inc. Dr. Beth Mynatt and I developed a range of mobile apps and 
tools at Georgia Tech. Dr. Cam Escoffery played a leadership role throughout and guided 
the use of survey instruments at Emory’s Rollins School of Public Health. Dr. Sookyong 
Koh and Kristen Hass helped to recruit families and provided epilepsy-related subject 
matter expertise at CHOA. Dr. Rosalind Picard and Daniel Bender provided E4 
wristbands as industry partners at Empatica Inc. Finally, Dr. Sandra was an early 
champion of our research. She helped us to secure funding and introduced us to staff 
working at the Emory University Hospital and CHOA epilepsy monitoring units.  
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CHAPTER 3. RELATED WORK 
This chapter presents related work within mobile and wearable self-reporting tools and 
how this work has informed my research and study designs. 
3.1 Data collection needs 
Important health data are often unavailable to clinicians during treatment. In practice, 
while patient and caregiver collected data is essential for informing epilepsy self-
management, specific aspects of these data collection needs remain poorly understood 
within the literature. 
1. It is important to understand patient and caregiver data collection needs with 
respect to self-management, 
2. It is also important to understand clinicians needs for informing treatment and 
then finally, 
3. It is important to communicate these needs to prospective technology developers 
to aid in the design of self-management health-tracking tools. 
3.1.1 Establishing patient and caregiver data collection needs - Epilepsy impacts every 
patient differently. It is common for clinicians to ask a range of questions during 
appointments. Interviews with families and clinicians at CHOA suggest that caregivers 
generally collect data by hand and maintain records in an ad-hoc manner (e.g. notepads 
and calendars). In an ideal case, this information helps families to learn patient symptoms 
and develop self-management practices; however, in practice patients and caregivers 
 
12 
provide either too much or too little information during clinical visits. There are no 
current standards for seizure reporting and no guidelines regarding data that patients find 
useful during the transition from pediatric to adult self-care. It would, therefore, be 
beneficial to investigate patient and caregiver data collection needs. 
3.1.2 Establishing clinical data collection needs - Neurologists need patients and 
caregivers to provide consistent and accurate self-reports for adjusting medications; 
however, these needs are not well defined in the literature. For example, a patient with 
poor sleep and a stressful week at school may have seizures regardless of medication. It is 
important to have accurate data in this case as a clinician must be able to distinguish 
between the effectiveness of medications for controlling seizures and poorly managed 
health behaviors. Furthermore, the relationship between clinical data collection needs and 
current self-reporting capabilities remains poorly understood. It is only recently that 
researchers have begun to survey clinicians for establishing a consensus regarding these 
needs[33], [42], [53].  
Paper and pencil seizure reporting templates have been published by non-governmental 
organizations (NGOs) such as American Epilepsy Society (AES) [54]. However, while 
these resources are reportedly popular among clinicians, the forms do not document sleep 
[16], exercise [18], stress [55] and other behaviors that are known to impact seizure 
likelihood from the literature [20]. Haut et al. [20] performed a paper seizure diary study 
among adult patients and identified behaviors that could predict seizures; however, these 
behaviors were not verified and no similar paper-based studies have occurred since then. 
Mobile and electronic seizure reporting studies have included a more exhaustive set of 
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reporting fields but tend to focus on patient responses as opposed to the attainment of 
specific clinical information needs [30], [43]. Le et al. [56] evaluated smartphone-based 
seizure diaries for documenting seizure events and reporting daily health information 
apps among both pediatric and adult patients with epilepsy [57], [58]; however, no 
clinical feedback was solicited, and no clinical implications were discussed. It would, 
therefore, be beneficial to investigate clinical data collection needs. 
3.1.3. Establishing data collection needs for guiding technology developers - Technology 
developers would benefit from guidance regarding how these platforms can address daily 
epilepsy-specific data collection needs among pediatric patients. Mobile and wearable 
devices have also been proposed for seizure detection [33], patient sleep, exercise, stress 
and medication intake data; however, limited research is available regarding the extent to 
which these technologies address clinical data collection needs (e.g. context-sensitive 
notifications). For example, Cramer et al. [59] employed a “smart” pill bottle to evaluate 
medication adherence among adult patients with epilepsy, but the study did not include 
pediatric patients. Whitney et al. [60] successfully employed pedometers among pediatric 
patients with epilepsy for investigating the relationship between physical activity and 
QOL, but the study was limited to one week [61], [62]. Interesting systems have also 
been proposed but not implemented. Fisher et al. [30] proposed using “biosensors” to 
reduce the burden of completing seizure diary entries. No studies to date have followed 
up on these concepts. In other cases, research is based on outdated platforms or 
interactions such as mobile EMA using PDAs [63]. Moreover, manual seizure diary 
entries and automated seizure detection systems have traditionally been evaluated 
separately. There is an increasing need to investigate both approaches together for 
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supporting data collection. It would, therefore, be helpful to investigate the applicability 
of existing mobile and wearable device methods to inform technology developers. 
In studies, #1, #3 and #5, I surveyed patients, caregivers, and clinicians to establish data 
collection needs with respect to mobile and wearable self-reporting tools. My technology 
review in study #1 evaluated a broad range of inertial, video and multimodal seizure 
detection devices [33] with the aim of specifically addressing clinical data collection 
needs. In addition, in study #5, I expanded this scope to further investigate patient and 
caregiver data collection needs for guiding future technology development. 
3.2 Data collection quality 
Even when health data is available, it is often unreliable. Health reporting is an integral 
part of successful epilepsy self-management but requires consistency and reliability. 
Incomplete, inaccurate or poorly documented reports are common due to difficulties with 
collecting, reporting and interpreting this information. 
Mobile and wearable technologies serve to help patients and caregivers report more 
consistent, prompt and reliable data for clinical decision making, yet the daily use of 
these tools remains underexplored and evidence suggests that maintaining data collection 
practices over time can be difficult [64]. This presents three challenges with respect to 
data quality:  
1. It is important to understand the consistency, promptness, and reliability of patient 
and caregiver reported data for identifying how to best support clinical treatment,  
2. It is similarly important to understand the current performance of mobile and 
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wearable devices beforehand as a starting point for making improvements, and 
finally,  
3. It is important to understand clinical data quality requirements for establishing 
how to best utilize input from patients and technologies. 
The following sections discuss each of these challenges in more detail: 
3.2.1 Improving data quality among patients and caregivers - The state of patient and 
caregiver data quality is currently not well understood. The consistency, promptness, 
reliability and social stigma associated with data collection can each impact the quality of 
data that clinicians receive during treatment, yet these issues have largely been ignored 
within the literature [30]. Most patients are unable to report seizures at night due to 
cognitive impairment [24]; similarly, caregivers are often less able to observe patient 
seizures while sleeping at night. New onset epilepsy patients and caregivers typically 
report detailed health information during the first few months of treatment, yet they 
gradually collect less and less detailed information over time. Meanwhile, social stigma 
may contribute to further issues while at school such as foregoing medications or not 
documenting medication intake. Mainstream health tracking devices such as Fitbit [65] 
products are not specifically designed to report consistency, promptness, and reliability of 
self-regulatory behaviors that can impact seizure likelihood such as insufficient sleep. 
These issues present a host of challenges as incomplete or inaccurate self-reports can 
mask important changes such as “breakthrough” seizures [66] or seizure triggers during 
treatment. It is, therefore, important to establish patient and caregivers self-reporting 
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capabilities as a first step for improving data quality. 
3.2.2 Improving mobile and wearable data quality - Mobile and wearable technologies 
stand to greatly improve data quality during treatment [67]. So far, few studies have 
quantified these performance requirements. Additionally, there can be considerable 
performance variation between devices. Health tracking devices such as the Fitbit 
pedometer have been shown to perform well when compared against clinically validated 
medical instruments [32], [68]; however, seizure detection devices continue to exhibit 
considerable performance variation [33]. FDA approval can be expensive and time-
consuming. Further, a majority of commercial products are not evaluated in clinical 
settings. My technology review highlighted considerable variability with respect to data 
quality [33]. For example, Beniczky et al. [69] and Lockman et al. [70] each evaluated 
similar inertial sensing wristbands; however, Beniczky reported 0.2 false alarms per 24 
hours with the Epi-Care Free [69] while Lockman reported 204 false alarms per 24 hours 
with the Smartwatch [70]. It is, therefore, important to conduct similar studies for 
establishing the extent to which mobile and wearable devices can improve data quality. 
3.2.3 Improving clinical data quality - Even as the quality of data from wearable devices 
can be improved, the data itself needs to align with clinical requirements during epilepsy 
treatment and patient self-care. 
 Importantly, there are currently no standards with respect to self-reporting; clinical data 
quality requirements are not well explored within the context of designing mobile and 
wearable technologies for supporting epilepsy treatment. In the past, considerable 
research has focused on seizure detection [69], [70] with less emphasis on the required 
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quality, feasibility, and interpretation of self-reported data [42]. There is evidence to 
suggest that additional components such as context-sensitive notifications [71], goal 
setting [2] and incentives [72], [73] could stand to further improve data quality; but few 
studies have investigated these approaches among adolescent pediatric patients with 
epilepsy. It is, therefore, important to establish clinical data quality requirements in order 
to align current patient and caregiver, and technology capabilities for improving data 
quality during treatment. 
In studies, #2, #4 and #5, I investigated data collection quality with respect to patient and 
clinical data collection needs, and evaluated the performance of a recent commercial 
seizure detection wristband [74] that may be applicable for long-term patient use outside 
the clinic, and addressed current gaps in the literature by focusing on pediatric patient 
populations. In study #5, I further investigated the impact of mobile and wearable 
technologies, context-sensitive notifications and the impact of motivational strategies on 
the quality of patient and caregiver collected data (i.e, consistency, promptness, and 
reliability between patient and caregiver collected responses). 
3.3 Data collection evaluation 
Even when health data is captured well, benefits to self-management outcomes are rarely 
quantified. Mobile and wearable tools need to be designed for daily use. Daily routines 
and habits can be difficult to change. Health tracking and fitness devices are frequently 
abandoned within the first few months of use [75] with estimates as high as one-third of 
devices being abandoned after the first month [76]. It is, therefore, important to 
investigate the practical implications of mobile and wearable data collection and self-
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management tools within the context of daily routines. 
These practical issues present the following three challenges for data evaluation:  
1. It is important to evaluate tools in terms of daily patient and caregiver context of use, 
2. It is also important to evaluate tools in terms of social acceptability, and finally, 
3. It is important to evaluate tools in terms of health metrics that are associated with 
effective patient self-management. 
3.3.1 Evaluating daily context of use - Mobile and wearable data collection tools should 
be practical for patients and caregivers to use on a daily basis yet the relationship 
between the consistency, promptness, and reliability of self-reporting responses remains 
poorly understood. Electronic seizure diary studies have reported response rates [30], 
[63]; however, these studies have yet to examine self-reporting with respect to other types 
of tools (e.g. counters and seizure detection devices). The context of these interactions 
has not been explored in detail. Haut et al. [63] collected the time of each self-report but 
did not include any additional contextual information that may be able to help account for 
possible social influences (e.g. geographic location or caregiver proximity). In some 
cases, patients may experience different levels of self-reporting burden depending on 
time and place during the day. It may be crucial to consider the context of use for 
frequent and consistent utilization. 
3.3.2. Evaluating social acceptability - The social acceptability and context of mobile and 
wearable tools must also be considered and are poorly understood among adolescent 
patients. Benson et. al. [23] studied the social impact of epilepsy among adolescents and 
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highlighted a strong desire to conceal epilepsy from others. Borus. et al. [77] found that 
while adolescent patients aged 15-24 benefited from Continuous Glucose Monitoring 
(CGM), patients in this age group had poor adherence compared to adults. “30% of 
adolescent patients used the technology for 6 or more days per week compared with 86% 
of patients older than 25 years and 50% of patients aged 8-14 years” [77]. It may, 
therefore, be important to investigate social stigma surrounding pediatric self-reporting 
tools to encourage adoption. 
3.3.3. Evaluating patient health metrics - Finally, data collection tools must be evaluated 
in terms of health outcomes that are important for pediatric patients with epilepsy. To do 
this, I evaluated a subset of questions from the Self-Efficacy for Managing Chronic 
Disease 6-item Scale (SEM-CD) [78] and Patient Activation Measure (PAM) [79] as 
indicators that have been linked with effective pediatric self-management [2]. Increased 
AESMMI and PAM scores have been linked with improved self-management outcomes 
[1]. In addition, practices that help in reflecting on and documenting health behaviors are 
important skills for adult self-care. It is therefore important to evaluate measures that 
relate to these skills and have been linked with successful patient self-management. 
In study #5, I evaluated the following: 1) context of use with respect to mobile phone 
location and patient and caregiver proximity when using a mobile application for 
anticipating convenient times and places to issue notifications to complete daily self-
management practices, 2) social acceptability of using intake and exit surveys, and 
finally, 3) changes in  patient engagement between intake and exit. 
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3.4 The state of epilepsy-specific self-reporting 
The research community has been slow to investigate the potential benefits of mobile and 
wearable computing tools within epilepsy self-management for three reasons:  
3.4.1. Health tracking and self-reporting performance requirements are often 
unspecified. Health tracking devices are typically not validated against clinical 
instruments. Likewise, self-reporting requirements are typically not described in terms of 
specifications for health tracking technologies. In this case, the goal is to find a middle 
ground. Health tracking devices may be more than sufficient for answering certain types 
of questions. In addition, galvanic skin response (GSR) and heart rate variability (HRV) 
sensing is becoming increasingly available among wearable fitness devices such as the 
Fitbit Charge 2 [65] and may be useful for helping patients to recall behaviors or reflect 
on stressors over time. It is, therefore, important to establish performance and self-
reporting requirements for determining appropriate devices and applications to study. 
3.4.2. Seizure diary apps do not incorporate data from health tracking devices.  
Existing seizure diary systems do not receive data from health tracking devices. 
Scheherazade et al. [56] studied smartphone seizure diary usage among 1,944 adolescent 
and adult patients with epilepsy. The app asked users to document seizure events, sleep, 
mood, side effects, medication intake along with additional information such as uploaded 
photos and video and reporting menstrual cycles in the case of female users. Many of 
these health indicators can now be collected automatically using wearable health tracking 
devices instead of being entered by hand. In addition, the native Android and iOS mobile 
operating systems have each introduced “health” services for simplifying the storage and 
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access of health-related data from a range of health tracking devices. These challenges 
present immediate opportunities for reducing the current data entry burden of mobile 
seizure diary apps and enabling patients to more easily reflect on data collected from 
existing health tracking devices. 
3.4.3. Long-term adoption of such devices necessitates that patients and caregivers find 
data collection devices to be useful.  
The literature highlights a critical need for understanding and shaping patient and 
caregiver data collection needs. This need is especially true among pediatric patients. 
Haut et al. [63] evaluated twice daily mobile phone surveys among adult patients with 
epilepsy. The survey completion rates were excellent with patients completing diaries for 
a median of 112 days [63]. No such studies have compared responses with automated 
seizure reporting or been conducted with pediatric patients, and similarly, no such studies 
have investigated the use of self-reporting tools that utilize input from wearable health 
tracking devices beyond the clinic. Furthermore, no studies have directly compared the 
reliability of seizure diary reporting between patients and an external collector such as a 
caregiver. More work is warranted in order to understand patient and caregiver needs, 
and establish the extent that these approaches may be applicable among pediatric 
patients. 
If successful, these approaches could reduce self-reporting overhead by enabling passive 
health tracking devices to answer questions that patients and caregivers would otherwise 
have to enter by hand (e.g. “Did you get more than 8 hours of sleep last night?”) or by 
helping patients to reflect on past behaviors when answering questions (e.g. seizure diary 
 
22 
apps include questions on emotional state). 
3.4 Research Traditions & Methods 
3.4.1 Everyday computing perspective 
My research is inspired by perspectives from everyday computing. Everyday computing 
considers computing challenges that scale across time, space and stakeholders [80]. It can 
be hard to change people’s daily routines. In this case, supporting patient and caregiver 
self-management requires designing not only for specific moments but also between 
appointments. This perspective can help us to preemptively consider problems. 
My mobile Ecological Momentary Assessment (EMA) studies draw on these perspectives 
both in terms of being conducted “in the field” and also scaling data collection needs, 
interactions and outcomes over time, place and between multiple stakeholders. 
1. Scaling across time - Interruption is a fact 
of life. More than “walk up and use”. Future data collection tools need to support data 
collection that takes place over time and takes into account frequent interruptions and 
the patients’ social and environmental context when reminding them to complete 
specific tasks. Impaired cognition can make it difficult for some patients to promptly 
report seizures. In study #5, I attempted to make maintaining data entry as effortless 
as possible by sending reminders that attempt to anticipate patient self-reporting 
delays based on patient input during an intake survey and ensuring that patients and 
caregivers can resume partially completed surveys for anticipating interruptions. 
2. Scaling across context - Mobile app 
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reminder notifications need to be delivered at the right time and place throughout the 
day. In study #5, I integrated contextual information to infer when patients are busy at 
school and used geospatial and wireless proximity information to prompt interactions 
between patients and caregivers. In this work, I further attempted to prioritize app 
notifications during the most effective times and places for encouraging consistent, 
prompt and reliable self-reporting along with wearable device adherence. 
3. Scaling between stakeholders - Mobile 
apps need to support input from multiple stakeholders. For example, caregiver 
observations are often required for reporting nighttime seizures, and pediatric patients 
often require assistance with remembering to take medications until developing these 
skills on their own. Most self-management tools are designed for a single adult user 
[64]. Epilepsy self-management extends beyond the patient. In study #5, I designed a 
mobile app around the need for joint patient and caregiver data collection, data access 
and self-reflection. 
My goal has been to apply these Everyday Computing perspectives to help provide an 
even greater contribution to the HCI and health communities, offering contemporary 
mobile and wearable design implications that account for the fluid and “messy” nature of 
daily computing interactions.  
3.4.2 Ecological Momentary Assessment (EMA) 
My studies are also inspired by Ecological Momentary Assessment (EMA) as a study 
design method from behavioral science and HCI fields. 
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“Ecological momentary assessment (EMA) refers to a collection of methods often used in 
behavioral medicine research by which a research participant repeatedly reports on 
symptoms, affect, behavior, and cognition close in time to experience and in the 
‘participants’, ‘natural environment’ [81]. This broad definition describes surveys that are 
administered within a patient’s natural “environment” during specific times [82], [83] as 
opposed to before or during a clinical appointment. These survey assessments are 
typically administered on either a schedule of pre-scheduled or randomized events such 
as with “beeper” and “experience sampling” studies [84] from HCI or triggered based on 
based on behavioral events such as an increased heart rate [85].  
Notable benefits of EMA over traditional surveys include responses that are collected in 
the “real-life context of the environment” [86] (i.e. ecological validity) and with reduced 
recall bias. In general, the more responses generalize to everyday settings the better in 
terms of collecting accurate health data (i.e. ecological validity); meanwhile, the more 
recent the event the fewer participants were influenced by problems such as imperfect 
memory [87]. This approach offers convenience to researchers and respondents alike as 
mobile phone survey websites can be used to create surveys that can be completed from 
anywhere; native smartphone applications are also available for offering additional 
convenience and native reminder notifications [67]. In the case of epilepsy treatment, 
neurologists rely greatly on access to accurate patient and caregiver feedback for 
adjusting medications.  
Notable drawbacks include both validating responses and random sampling at 
inopportune times. For example, in an ideal situation, researchers and clinicians would be 
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able to observe a patient in his or her natural environment without influencing his 
behavior. In practice, researchers may not be able to observe patients in person and 
therefore be unable to account for the reasons behind notable behaviour changes over 
time (i.e, stress levels throughout the course of a day). Moreover, the "mode of 
questionnaire administration can have serious effects on data quality" [88]. For example, 
“events important to the researcher may be missed”. “If someone is socially anxious and 
has only a few social interactions in a day, all these events may be missed if signals do 
not co-occur during the times of the social interactions. Important events can be defined 
to instigate their recording” [89]. 
Mobile EMA is increasingly recognized as a viable and preferred approach over paper 
and audio based methods for assessing patient health changes between appointments [86], 
[87]. Health surveys are often completed in waiting rooms for this type of data, however 
being in a clinical setting and recalling details from the last visit is known to impact the 
quality of responses (i.e, recall bias) [87]. Many respondents feel anxious (i.e. white coat 
hypertension [90] or put on the spot or rushed with a doctor present (i.e. Hawthorne 
effect or observer effect [91]). Meanwhile, biographical memory limitations can make 
accurate recall difficult or impossible since the last visit. EMA instruments can provide a 
more accurate picture of patient behaviors by administering surveys in the patients’ 
natural environment over multiple sessions, rather than a single sitting, and additionally 
recorded to account for backfilled responses. Lastly, mobile EMA studies have a long 
history and have been successfully used for collecting data among adult patients with 
epilepsy [64] and pediatric patients with chronic conditions. Internet-enabled 
smartphones and the advent of apps such as LifeData [92] and RedCap [93] have 
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simplified EMA survey deployment in recent years. 
My work in study #5 utilized a mobile EMA app. In addition, to administering patient 
and caregiver surveys my EMA app collected patient and caregiver contextual data such 
as location and patient-caregiver proximity as additional information for anticipating 
response validity throughout the day [32] (e.g. enabling survey reminders to be sent when 




CHAPTER 4. RESEARCH NARRATIVE 
4.1 Thesis statement, Research Questions, and Contributions 
In this thesis, I present the design, development, and evaluation of mobile and wearable 
pediatric epilepsy self-management tools and interventions for supporting patients, 
caregivers, and clinicians. My thesis statement is as follows: 
Epilepsy self-management can be improved through the introduction of mobile and 
wearable interventions that enable adolescent patients and family members to 
collect the types and characteristics of data that clinicians need during epilepsy 
diagnosis and treatment, respectively, and also increase patient engagement as an 
indicator of successful, future self-management in preparation for adult self-care. 
My initial research aided in clarifying clinical data collection needs as well as the 
feasibility and impact of mobile and wearable data collection interventions on patient 
self-reporting and self-efficacy. In the process, I identified an urgent need to better 
support patient and caregiver self-reporting and self-management along with notable 
strengths and shortcomings of current data collection tools. I then investigated several 
new mobile and wearable technology interventions aimed at helping patients and 
caregivers to collect a broader set of health information during treatment. Table 1 




Table 1 - Research results and study-specific research questions 
Research Results Study # Questions 
1 Establish data collection needs     
  
What are patient, caregiver and clinician 
data collection needs during treatment, 
and how do these needs translate into 
mobile and wearable design 
specifications? 
1 What data do clinicians need vs. what can technology provide now 
as a starting point? 
  3 
What data do clinicians need vs. what patients can provide now as 
a starting point? consistency, promptness, and agreement? 
  5 
How do patient/caregiver attitudes towards clinical data collection 
needs compare before and after using mobile/wearable tools? 
2 Improve data collection quality     
  
How consistently and promptly can 
current patients/caregivers and 
mobile/wearable tools collect clinically 
relevant health data, and to what extent 
can tools be extended to improve data 
quality? 
2 To what extent can a seizure detection wristband improve the 
quality of “seizure count” data as compared with self-report? 
  
4 
To what extent can a patient/caregiver video review of wearable 
detected seizure events further improve the quality of “seizure 
count” data as compared with self-report?  
  
5 
How can mobile phone surveys help patients and caregivers to 
more 1) consistently and 2) promptly collect clinically relevant health 
data as a part of daily self-management practices? 
  
5 
To what extent are patients and caregivers able to consistently, 
promptly and reliably complete daily mobile phone surveys with 




To what extent can the additional use of health tracking devices and 
subsequent access to health tracking data improve 
patient/caregiver promptness and reliability? 
  
5 
How does data collected from active patient/caregiver surveys 




How can goal setting, point-based rewards and context information 
from mobile and wearable devices complement mobile phone 
surveys to help patients and caregivers to document self-
management behaviors and complete these behaviors on a daily 
basis? 
3 Evaluate patient self-efficacy scores 
  
How can mobile and wearable 
technologies improve patient self-efficacy 
as a starting point for designing effective 
data collection approaches and 
strategies? 
5 
How effective are mobile surveys for increasing patient health 
scores as proxies for successful health outcomes: patient self-
efficacy and activation? 
  5 
To what extent can mobile phone surveys and a clinical audience 
improve patient self-efficacy? 
  5 
To what extent can health tracking hardware and access to data 
summaries improve patient self-efficacy? 
  5 
What are the impacts of an additional mobile survey goal setting 




The remainder of this section will describe the progression of my research and findings in 
more detail. 
4.1.1 Establish data collection needs 
My first set of research questions reflect the importance of establishing data collection 
needs and the extent that these needs are being met by current technologies and current 
patient/caregiver data collection efforts. 
To address these research questions, in studies #1 and #3, I performed a literature review 
and surveyed practicing clinicians to establish a deeper understanding of clinical needs. 
These studies investigated the current state of clinical data collection needs with respect 
to the current state of mobile and wearable data collection devices and the current state of 
patient and caregiver data collection capabilities.  
Next, I sought to understand mobile and wearable computing needs from the perspective 
of patients and caregivers. My final study (#5) sought to clarify these needs by similarly 
administering intake/exit surveys to establish patient and caregiver attitudes and beliefs 
towards data collection while using a range of different mobile and wearable devices: 
smartphones, smartwatches, fitness trackers and proximity tags. 
4.1.2 Improve data collection quality 
My second research question reflects the need to investigate mobile and wearable tools 
methods and approaches aimed at improving data quality for supporting these needs.  
To address this research question, I first performed a technology review in study #1. The 
results established the performance of current seizure detection technologies as a starting 
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point for understanding and assessing clinical data quality requirements. Next, I 
established a research collaboration with a company called Empatica Inc. My research 
with the company in study #3 evaluated the performance of E4 seizure detection 
wristbands. The results showed that while the wristbands did provide seizure counts that 
were more accurate than unassisted patient self-reports from past studies, more work 
would be needed as devices over reported seizures.  
In study #4, I investigated using a video review as a possible approach for addressing this 
issue of data collection quality. The patients and caregivers were asked to review and 
annotate video footage of wristband-detected events. To date, we've seen near perfect 
agreement between patients/caregiver and electroencephalogram technicians. The initial 
results show that most patients and caregivers can indeed identify and reject video clips 
that do not contain seizure events and that correctly dismissing these false alarms can 
improve the overall quality of reported seizure counts.  
Then, in study #5, I evaluated the feasibility of patient and caregiver mobile and wearable 
platforms for increasing the consistency and promptness of traditional paper-based 
seizure diary entries. In addition, I investigated the extent that patients and caregivers can 
consistently and promptly collect health data using a range of mobile and wearable 
devices: smartphones, proximity tags and health tracking devices. 
4.1.3 Evaluate patient self-efficacy and patient activation scores 
Finally, my third research question reflects the need to evaluate relevant clinical patient 
health outcome impacts of these mobile and wearable data collection tools. In studies #5, 
I included three self-efficacy questions from the Self-Efficacy for Managing Chronic 
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Disease 6-item Scale (SEM-CD) [78] and the full, thirteen-item Patient Activation 
Measure (PAM) [79] as instruments linked with successful patient self-management. 
Intake and exit SEM-CD and PAM questions were administered to evaluate the “degree 
of confidence that individuals have in their ability to perform tasks within medication 




CHAPTER 5. RESEARCH CONTRIBUTIONS 
My research has made a positive impact on both the lives of patients, caregivers and 
clinicians, and to the fields of HCI and health informatics by contributing to the design 
and development of epilepsy self-management tools.  
In the past, few studies had investigated self-reporting data collection needs among 
epilepsy clinicians [23]. Important considerations such as data collection consistency, 
promptness, and reliability were poorly understood prior to our research [31].  
My contributions included 1) developing and evaluating new mobile and wearable data 
collection approaches, 2) providing design implications to guide the future development 
of mobile and wearable technologies, and 3) inform in the state of personal data captured 
outside of the clinic to support patient outreach pediatric transition to adult self-care.  
Table 2 highlights the relationship between my research studies and objectives. 
Table 2 - Research studies and objectives 
Studies 1. Establish data 
collection needs 
2. Improve data 
collection quality 
3. Evaluate patient 
self-efficacy and 
activation scores 
#1 Epilepsy technology needs review ✓   
#2 Neurocognitive self-reporting needs ✓   
#3 Seizure detection wristband evaluation  ✓  
#4 Rejection of non-seizures from retrospective 
video of wristband events 
 ✓  
#5 Mobile/wearable data collection surveys ✓ ✓ ✓ 
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CHAPTER 6. RESEARCH STUDIES 
6.1 Study #1 - Epilepsy technology needs review 
My first study established clinical data collection needs from a clinician and technology 
perspective by asking the question “What data do clinicians need vs. what can technology 
provide now as a starting point?” [33]).  
6.1.2 Summary 
Published - Seizures, ‘15 
Bidwell, Jonathan, et al. "Seizure reporting technologies for epilepsy treatment: A 
review of clinical information needs and supporting technologies." Seizure-European 
Journal of Epilepsy 32 (2015): 109-117. 
 
Epilepsy diagnosis and treatment currently relies on patients and caregivers to collect 
health data for informing clinical decision making. However, patient and caregiver self-
reports are often either inconsistent, incomplete or unavailable. Many patients and 
caregivers struggle to collect the data that clinicians need. In turn, limited or inaccurate 
self-reports can result in misdiagnosis, untreated seizures and prolonged exposure to 
medication side-effects required before finding an effective AED. 
Mobile and wearable technologies stand to help address this challenge by helping patients 
and families to collect more consistent and reliable data, but clinical requirements for 
developing these tools are all but unknown. The purpose of this study was to establish 
design recommendations for mobile and wearable technologies as they relate to aiding 
clinical decision-making. I conducted interviews, a literature review, and a survey to 
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investigate clinical information needs during diagnosis and treatment. I then focused on 
these clinical needs during my subsequent research. 
The main contribution of this work is identifying a gap between reported sensing 
capabilities and the performance metrics that are needed for addressing clinical 
information needs. In the past, literature did not present consistent, standardized metrics 
for making performance comparisons between seizure detection devices and patients’ 
self-reporting capabilities. My review included a meta-analysis where I derived translated 
published performance in terms of F-score to compare performance between seizure 
detection devices and current patient self-report.  
My findings highlighted a strong need for helping patients and caregivers to collect more 
accurate seizure counts and further for helping to collect video to assist clinicians in 
distinguishing between generalized and focal patient seizure types. I also identified 
several shortcomings and future opportunities for designing mobile and wearable tools 
for supporting patients and caregivers data collection during epilepsy treatment. 
6.1.3 Related work 
Literature reviews from Pediaditis et al. [94] and Van de Vel et al. [95] provide a 
comprehensive overview of seizure detection technologies but do not investigate clinical 
information needs or comment on additional self-reporting technology opportunities 
beyond seizure detection. Moreover, the authors did not use a uniform set of statistics 
when reporting performance results. It was, therefore, difficult to make performance 
comparisons between systems. Finally, the studies were completed several years prior to 




The study had three main phases: The first phase of the study included interviews and 
surveys. We interviewed and surveyed 11 practicing neurologists and established a 
consensus that seizure counts, as opposed to seizure duration or intensity, were the most 
important clinical data type. 
The second phase of the study was a comprehensive technology review. The review 
included a broad range of existing research and commercial seizure detection devices but 
intentionally excluded EEG-based devices that are typically considered impractical for 
use at home.  
The third phase was to compare seizure detection performance to current patient self-
reporting. We reviewed the literature on patient self-reporting and selected studies that 
compared patient reports against the same type of video/EEG observations that were used 
for evaluating the seizure detection devices. We extrapolated F-scores values for each 
seizure detection device and patient self-reporting study and compared performance 




Figure 1 - Technology review seizure reporting performance comparison - 
Multiple types of non-EEG seizure detection systems are compared against 
patient self-reporting on a continuous F-score scale from 0.0 to 1.0, read left to 
right, where 0.0 is worst and 1.0 is shows the best performance (Please see 
Appendix A for a full page copy of the figure). 
6.1.5 Results 
In our questionnaire, 100% of neurologists reported that seizure count was the “most 
important” information that patients and caregivers could provide them during treatment; 
similarly, 100% of neurologists indicated they would like to have a video of patients prior 
to selecting an AED during an initial consultation. This information is particularly 
important for enabling neurologists to select the correct class of AED for patients during 
diagnosis and then subsequently for evaluating the efficacy of the AED during treatment.  
In our technology review, I further identified that only a subset of available technologies 
surpassed patient self-reporting performance due to high false positive rates. We 
observed that inertial seizure detection devices coupled with video capture for recording 
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seizures at night could stand to address collecting seizure counts that are more accurate 
than current patient self-reporting during day and night time use.  
Figure 1 presents an F1-score performance for each type of system alongside patient day 
and night time reporting for comparison. F1-score is a continuous scale from 0.0 to 1.0 
and can be read left to right, where 0.0 is worst and 1.0 is the best performance. Each 
seizure detection system is represented as a circle for given class technology. The circle 
color indicates the time of day that the system was evaluated and diameter represents the 
relative number of patients that had at least one seizure during each study. Self-reporting 
performance is shown using vertical lines where the leftmost line (blue) indicates 
nighttime performance and the rightmost line (orange) indicates daytime performance. 
6.1.6 Discussion 
My interview, survey, and technology review results highlighted four important findings: 
1. Neurologists need accurate self-reported seizure 
counts above all else. Treatment requires accurate seizure counts. All respondents 
(11 of 11 neurologists) reported that seizure counts were the most important data type 
to them during both diagnosis and treatment. This finding makes a strong case for 
introducing seizure detection devices to provide more accurate seizure counts. 
2. Low-cost video could help clinicians during 
initial epilepsy diagnosis. Initial diagnosis calls for accurate seizure descriptions. All 
neurology respondents reported they would like to have a video of patients prior to 
selecting an initial AED, however, only 30% of these respondents currently had 
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access to video from patients. In turn, providing families with video capture tools 
may be useful for distinguishing between patients with generalized and focal type 
seizure events. 
3. Existing devices are best suited for nighttime use 
when patients are less able to report seizures. High false positive rates remain 
problematic for the majority of day and night time seizure detection devices; 
presently only a subset of devices surpassed patient self-reporting during the day. In 
addition, most devices perform better at night than during the day as daytime 
activities such as teeth brushing are more difficult to distinguish from seizure-related 
movements. This finding suggests that existing devices may be most beneficial for 
use at night when patients have the most difficulty reporting seizures. 
4. Existing seizure detection devices work best for 
Generalized Tonic-Clonic Seizures (GTCs) that involve considerable limb 
movement. Existing devices are only capable of detecting GTC type seizures that 
involve considerable limb movement. This finding is critically important; only 30% 
of patients have GTC seizures that are characterized by limb movements by 
definition. By contrast, 70% of patients have focal seizures that do not necessarily 
exhibit limb movements. For example, focal dyscognitive seizures often present 
during sleep transitions and may involve lip smacking and vocalizations without limb 
movements. Furthermore, absence seizures are most common among younger 
patients and often include no motor movements at all. This finding suggests a need to 
measure additional signals based on a patient’s specific seizures and symptoms. The 
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good news from an activity recognition perspective. Most patients tend to present 
with the same symptoms over time. It may, therefore, be possible to build more 
accurate patient-specific models as proposed by Cuppens et. al [96]. 
My findings contribute to addressing existing knowledge gaps between current patient 
self-reporting, clinical information needs and patient and caregiver self-reporting 
technologies. In the past, researchers compared the performance of seizure detection 
devices [95] but did not compare performance with patient “self-report” and further did 
not investigate how clinicians prioritized seizure count to other types of information 
during “clinical decision making”.  
6.1.7 Conclusion 
In this study I conducted interviews, a literature review and a questionnaire to investigate 
clinical information needs during diagnosis and treatment, respectively. I then performed 
a detailed review of current seizure detection devices based on these needs and identified 
several underexplored design opportunities that would later guide my subsequent studies. 
The study highlighted strengths and shortcomings of current technologies and highlighted 
several opportunities for supporting epilepsy self-management. 
My paper was published in Seizures ‘15 and Intech Open Science, ‘17. I also presented at 
the Neurological Disorders Summit (NDS),’16. The review provided a first-of-its-kind 
comparison between the performance of these devices and patient self-reporting. These 
findings greatly informed my work. I have since come to see the data collection as an 
area that presents the greatest challenge to pediatric patients and is best suited for the 
capabilities of current technologies. 
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6.2 Study #2 - Neurocognitive self-reporting needs study 
Pending - Epilepsia, ‘18 
Bidwell, Jonathan, et al. "Investigating design opportunities for supporting patient self-
reporting among neurocognitive conditions" Epilepsia, ‘18 (planned submission) 
 
My second study investigated clinical data collection needs from a clinician and 
patient/caregiver perspective with the question “What data do clinicians need vs. what 
patients can provide now as a starting point?” 
My technology review in study #1 highlighted the need to further establish specific types, 
priorities, and characteristics of patient self-reported data. I began to consider how these 
self-reporting needs might translate to different schools of medicine that also rely heavily 
on patient self-reporting. In addition to speaking with neurologists specializing in 
epilepsy, I also began interviewing healthcare professionals from psychiatry and sleep 
medicine. I was surprised to learn that these fields also had few self-reporting guidelines. 
I initiated a study with my colleagues from CHOA and Emory to further clarify clinician 
information needs and better understand clinician perspectives regarding patient and 
caregivers self-reporting capabilities. The results built on my findings from study #1 and 
helped me to prioritize self-reporting needs to collect in study #5 such as mental health. 
6.2.1 Summary 
The treatment of neurocognitive conditions relies heavily on patient self-reporting to 
inform treatment and stands to benefit from the development of technological tools that 
support patient data collection activities and shared decision making between patients and 
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providers. Health tracking technologies stand to help patients and caregivers collect this 
data but technology developers need guidelines for developing these tools. The specific 
types and characteristics of the data that clinicians need are not well known.  
The purpose of this study is to establish clinical information needs among clinicians from 
additional neurological fields: sleep and psychology to examine similarities that may be 
relevant given comorbidities between epilepsy, narcolepsy, and depression. In this study, 
my colleagues and I conducted a literature review to establish an initial list of relevant 
symptoms and triggers among specialized providers in neurology, psychiatry, and sleep 
medicine. In-person expert panel sessions were then conducted with 14 clinicians (5 
epilepsy, 4 psychiatry, and 5 sleep medicine specialists) to assess clinician use of these 
symptoms and triggers as patient-reported data during diagnosis and treatment. Then a 
survey was conducted to establish a consensus regarding the availability and quality of 
patient data being collected. 
The resulting findings highlighted several important yet underexplored data collection 
and design opportunities for supporting the diagnosis, treatment, and self-management of 
these three fields as well as expose gaps between clinical data needs and patient practices. 
The main contributions of this work have included: 
1. Identification of the type, priority, and characteristics of self-reported data that 
clinicians need from patients. 
2. Identification of common clinical self-reporting needs between traditionally separate 
medical fields. 




6.2.2 Related work 
The treatment of neurocognitive conditions relies heavily on patient self-reporting to 
inform treatment and stands to benefit from the development of technologies that support 
patient data collection and shared decision making between patients and providers.  
Medical professionals often ask patients to collect and report health-related data for 
informing clinical decisions; however, patients often struggle with self-reporting 
responsibilities due to a range of social, technical and organizational barriers [1], [4]. 
This type of feedback is central to the diagnosis and treatment of neurocognitive 
conditions as clinical specialists must often rely on patient and caregiver self-reports that 
are often incomplete, inconsistent or inaccurate in the absence of more easily quantified 
information. For example, epilepsy, psychiatry and sleep medicine specialists often ask 
patients to keep track of factors such as mood that may be subjective and difficult for 
patients to accurately report between appointments. Interpreting quantitative measures 
such as patient blood glucose levels in the case of diabetes is typically much easier for 
clinicians by comparison. 
Many patients struggle with self-reporting responsibilities due to a range of social, 
technical and organizational barriers [1], [4]. Health tracking technologies [6] and health 
reporting tools [7] have the potential to greatly reduce the burden placed on patients and 
collect more clinically significant health information [9]; however, building effective data 
collection tools requires understanding clinical data needs. These needs are often 
unknown or underspecified in the medical literature.  
 
43 
In this study, I sought to establish design guidelines for addressing two gaps within the 
related work. There is a need to establish both 1) patient health reporting capabilities in 
order to align data collection efforts with clinician needs and expectations and 2) 
additional parameters such as the type, priority, and characteristics of the desired health 
reporting data in order to develop effective mobile and wearable data collection tools. 
6.2.2.1 Patient Self-reporting challenges 
Health information can also be challenging for patients to collect and therefore be 
unreliable even when available or collected too infrequently to be informative [82], [97]. 
These issues present notable challenges for patient care: 
1. Reporting availability - Patient self-reporting is often relied upon heavily 
or exclusively but critical information may not be available due to social stigma [23], 
nonadherence [98] or inability to observe clinical presentations [24], [99]. Sometimes 
there may be simply a lack of awareness of what information is relevant for patients 
to collect and bring to appointments such as in the similar case of patients with 
chronic migraines [97]. For example, neurologists who treat epilepsy know that most 
patients (> 85.5%) are unable to observe seizure events at night [24] also resulting in 
missing data [30], [100]. 
2. Reporting usefulness - Patient self-reported data may not include the 
right level of detail for a clinical consultation. For example, consumer health and 
wellness devices may collect data that is unsuitable for certain applications [101] or 
patients may not know what information to collect due to a large number of possible 
symptoms and triggers [102]. Furthermore, to the best of our knowledge, there are no 
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standard data collection apps, forms or guidelines for informing this process. 
3. Reporting reliability - Patient self-reporting may not agree with clinical 
measurements. For example, numerous studies have also questioned the validity of 
both objective and subjective methods for measuring aspects of sleep monitoring 
within the sleep medicine field [103], [104]. Many patients struggle to maintain paper 
and pencil diaries documenting changes in mood [105]. Non-compliance and recall 
bias [87] also present similar barriers to mental health [30], [87]. In addition, 
measurement validity can be difficult to assess given absence of quantitative 
measurements or validated study designs [30].  
4. Reporting difficulty – Patient self-reporting can be difficult and 
burdensome for patients to collect between appointments [106]. Neurologists and 
psychiatrists often ask patients to document and report data such as the time, date and 
a description of symptoms before, during and after clinical presentations [30], [105], 
[107]. For example, neurologists often ask patients to keep a food journal to help 
identify possible triggers of migraines. 
5. Reporting frequency - Finally, self-reporting may not be frequent enough 
to enable clinicians to adjust seizure control medications between appointments. For 
example, caregivers of patients with infantile spasms (IS) need to be especially 
careful to provide frequent and detailed seizure reports [53] as uncontrolled seizures 
can have tragic lifelong consequences such as decreased cognitive function [108]. In 
other cases, self-reports may be documented too frequently and result in “information 
overload” for clinicians seeking to interpret self-reports within a typical 15-minute 
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clinical visit [109], [110]. 
6.2.2.2 Health tracking design challenges 
Health tracking priorities among clinicians and the patients’ role in self-reporting are 
each often under-specified in the literature. There is considerable interest in behavioral 
surveillance [111] as input for both assessing, diagnosing chronic conditions [112] and 
evaluating self-management during treatment. However, little is known regarding what 
data should be collected, when it should be collected, and how this data monitoring 
benefits patient care. The Chronic Care Model [2], [113] is instructive for understanding 
the role of clinical systems and self-management within patient care but does not clarify 
specific types of clinical information that patients should keep track of for informing 
treatment and similarly does not recommend specific self-management practices for 
achieving positive long-term outcomes. 
Health tracking technologies can play a major role in reducing the burden of patient data 
collection [114], but the current literature provides limited guidance regarding the 
specific types and characteristics of data that clinicians need patients to collect for them. 
Non-regulated health and wellness devices and regulated medical devices tend to play 
different roles when it comes to answering clinical questions during diagnosis and 
treatment [115]. For example, the Fitbit Charge 2 [116] can measure step count and sleep 
but is not designed to answer specific clinical questions such as “how did the patient’s 
resting heart rate change after prescribing a stimulant?”. By contrast, the Natus 
Ambulatory EEG [117] is designed to answer a narrow set of clinical questions, such as 
“where is a seizure originating?”, but does not provide physical activity or sleep 
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information as more general parameters that can impact seizure likelihood. 
It is therefore important for research to address this mismatch between technology data 
collection requirements and clinical data collection needs for informing diagnosis and 
treatment. If researchers can establish these clinical information needs then technology 
developers may be able to more effectively prioritize development within specific clinical 
areas [118] and develop new products that better indicate and address patient self-
reporting needs. Meanwhile, mental health is receiving increased attention from 
researchers with efforts to predict patient depression from speech [119], social media 
usage [120] and facial expressions [121]. While these advancements are promising, a 
more systematic approach to understanding patient data needs could better inform the 
development of such technologies as health tracking data collection tools [122]. 
6.2.3 Methods 
The first phase of the study was to establish an initial list of self-reporting data collection 
needs. I conducted a literature review and worked with subject matter experts to establish 
a list of important symptoms and triggers within epilepsy, psychiatry and sleep medicine, 
respectively.  
I then conducted card-sorting exercises with 4-5 neurologists from each subspecialty. The 
card-sorting panels included 5 epilepsy providers at Children’s Healthcare of Atlanta, 
GA, 4 psychologists at the Grady Memorial Hospital, GA and 5 sleep specialists at the 
Emory Sleep Center, GA. 
The second phase of the study was to survey neurologists for prioritizing this list of 
 
47 
sorted needs. I administered an online survey to 20 additional clinicians over a 5-week 
period. The respondents included 4 mid-level nurse practitioners who treated patients 
with epilepsy, 2 epileptologists, 6 psychiatrists and 8 sleep specialists. 
6.2.4 Results 
6.2.4.1 Self-reporting needs 
The first step for our research was establishing the type of patient self-reported data that 
clinicians need from patients. I began by interviewing 1-2 subjects matter experts from 
each subspecialty. I then performed a literature review to construct a corresponding list of 
useful symptoms and triggers to consider when diagnosing and treating each condition. 
The lists are summarized in Table 3 for reference and each included between 66 and 96 
symptoms and triggers. The complete lists can be made available available upon request. 
Table 3 - Symptoms and triggers by neurocognitive condition 
  Epilepsy Major Depression Narcolepsy Total 
Symptoms 48 49 53 150 
Triggers 11 23 43 77 
Total 66 72 96 234 
 
6.2.4.2 Self-reporting priorities 
Next, I investigated the priority of the patient self-reported data and compared the 
priorities between neurocognitive fields. The “top 20” highest ranked symptoms and 
triggers are shown in Table 4. The table highlights specific characteristics of the self-
reported data that clinicians need from patients.  
 
48 
Table 4 - List of clinical patient self-reporting needs during diagnosis & treatment 
Rank Symptom/trigger 
Useful 
(% reported yes) 
Available  
(% reported yes) 
Reliable 
(% reported yes) 
Difficult 






1 Status seizures 100.00% 100.00% 83.33% 16.67% 33.33% 
2 > 2 seizures in 24 hours 100.00% 100.00% 83.33% 0.00% 33.33% 
3 Patient Age 66.67% 83.33% 100.00% 0.00% 33.33% 
4 Daytime seizures events 100.00% 100.00% 50.00% 16.67% 50.00% 
5 Nighttime seizure events 100.00% 33.33% 33.33% 66.67% 33.33% 
6 Auras (pre-ictal)  100.00% 50.00% 50.00% 66.67% 16.67% 
7 Viral infections 83.33% 16.67% 33.33% 33.33% 16.67% 
8 New onset of cancer 83.33% 50.00% 83.33% 0.00% 16.67% 
9 Seizures at sleep transitions 83.33% 33.33% 66.67% 16.67% 16.67% 
10 Impaired sleep and daytime 
alertness 
83.33% 50.00% 50.00% 33.33% 16.67% 
11 Seizure onset time at night 66.67% 33.33% 0.00% 83.33% 16.67% 
12 Drug & alcohol use 66.67% 33.33% 16.67% 50.00% 16.67% 
13 Menstruation cycles 83.33% 33.33% 50.00% 33.33% 50.00% 
Rank Symptom/trigger 
Useful 
(% reported yes) 
Available  
(% reported yes) 
Reliable 
(% reported yes) 
Difficult 





14 New pregnancy 83.33% 50.00% 83.33% 16.67% 33.33% 
15 Academic decline 100.00% 16.67% 50.00% 16.67% 16.67% 
16 Impaired language abilities 83.33% 50.00% 66.67% 33.33% 16.67% 
17 Depression symptoms 83.33% 66.67% 33.33% 66.67% 16.67% 
18 Suicide attempts 83.33% 16.67% 33.33% 83.33% 16.67% 
19 Impaired memory 100.00% 33.33% 0.00% 33.33% 16.67% 
20 Heart disease 50.00% 0.00% 66.67% 16.67% 16.67% 
Major Depression  
1 Suicidal thoughts 100.00% 100.00% 83.33% 0.00% 50.00% 
2 Decreased need for sleep 100.00% 100.00% 66.67% 50.00% 16.67% 
3 Depressed mood  100.00% 100.00% 66.67% 33.33% 33.33% 
4 Fatigue/loss of energy 100.00% 100.00% 66.67% 16.67% 33.33% 
5 Hopelessness 100.00% 100.00% 83.33% 16.67% 33.33% 
6 Loss of interest in activities 100.00% 100.00% 83.33% 16.67% 33.33% 
7 Psychomotor 
retardation/agitation 
100.00% 100.00% 33.33% 50.00% 33.33% 
8 Trouble concentrating 100.00% 100.00% 50.00% 33.33% 33.33% 
9 Weight loss/gain 100.00% 100.00% 50.00% 50.00% 50.00% 
10 Worthlessness/guilt 100.00% 100.00% 100.00% 0.00% 33.33% 
11 Drug & alcohol abuse 100.00% 100.00% 16.67% 83.33% 33.33% 
12 Insomnia /hypersomnia 100.00% 100.00% 83.33% 16.67% 33.33% 
13 History of antidepressant 
medications 
100.00% 100.00% 50.00% 66.67% 0.00% 
14 Impaired sleep quality 100.00% 100.00% 66.67% 33.33% 16.67% 
15 Increased sleep latency 50.00% 50.00% 50.00% 50.00% 33.33% 
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16 Insomnia 100.00% 100.00% 50.00% 50.00% 16.67% 
17 Lower sleep efficiency 100.00% 100.00% 33.33% 66.67% 33.33% 
18 PTSD 100.00% 100.00% 66.67% 33.33% 16.67% 
19 Postpartum depression 83.33% 66.67% 33.33% 66.67% 0.00% 
20 Pregnancy 100.00% 100.00% 66.67% 0.00% 16.67% 
Narcolepsy  
1 History of napping within the 
same day 
75.00% 87.50% 37.50% 0.00% 0.00% 
2 Loss of muscle control 
(cataplexy) 
87.50% 87.50% 75.00% 37.50% 37.50% 
3 Hallucinations 87.50% 87.50% 50.00% 37.50% 37.50% 
4 Excessive sleep movements 87.50% 87.50% 37.50% 100.00% 25.00% 
5 Sleep paralysis at sleep 
transitions 
87.50% 87.50% 62.50% 25.00% 12.50% 
6 Irregular sleep jerks 75.00% 87.50% 37.50% 87.50% 12.50% 
7 Sleep paralysis 87.50% 87.50% 75.00% 37.50% 25.00% 
8 Paroxysmal sleepiness 87.50% 87.50% 25.00% 37.50% 25.00% 
9 Motor disorders during sleep 87.50% 87.50% 50.00% 37.50% 12.50% 
10 Daytime sleep attacks  100.00% 87.50% 25.00% 12.50% 25.00% 
Rank Symptom/trigger 
Useful 
(% reported yes) 
Available  
(% reported yes) 
Reliable 
(% reported yes) 
Difficult 





11 Impaired ability to drive 100.00% 87.50% 12.50% 37.50% 37.50% 
12 Efficacy of short naps 87.50% 75.00% 50.00% 37.50% 12.50% 
13 Rousing behaviors 87.50% 75.00% 62.50% 12.50% 12.50% 
14 Active sleepiness 100.00% 87.50% 25.00% 25.00% 37.50% 
15 Consequences of sleepiness 100.00% 87.50% 50.00% 37.50% 25.00% 
16 Intake of caffeine 100.00% 87.50% 62.50% 0.00% 12.50% 
17 Excessive sleepiness 87.50% 87.50% 50.00% 25.00% 12.50% 
18 Subjective sleepiness 87.50% 87.50% 50.00% 12.50% 0.00% 
19 Passive sleepiness 100.00% 87.50% 37.50% 12.50% 25.00% 




6.2.4.3 Self-reporting consensus 
6.2.4.3.1 Self-reporting data types and characteristics 
Table 5 summarizes our key research findings in terms of design implications for 
neurocognitive self-reporting tools. The table shows the “top 2” most reported survey 
responses after filtering for responses in terms of ‘symptom/triggers’ that were 
considered either “useful but not available” or “useful but difficult to collect”.  
In addition, the table is intended to serve as a design reference for developing patient self-
reporting technologies and highlights clinician consensus regarding 1) priority and 2) 
characteristics of select patient health indicators during diagnosis and treatment. 
Table 5 - Neurological condition and self-reporting design implications 











Depression / Suicide attempts Yes No Yes No Manual reporting with validated survey 
Medical history / History of 
Presenting Illness (HPI) 
No Yes No No Manual reporting with non-validated 
survey 
Major Depression 
Trouble concentrating Yes No Yes Yes Manual reporting with validated survey 
Weight gain/loss Yes Mixed Yes No Automated data collection and reporting 
Narcolepsy 
Impaired ability to drive Yes Mixed Yes Mixed Manual reporting with automated 
contextual prompts 




6.2.4.3.2 Low inter-rater agreement within conditions 
Next, I calculated Krippendorff's alpha (α) percent agreement between clinician survey 
responses within each of our neurocognitive conditions: epilepsy, major depression, and 
narcolepsy. α controls for agreement by chance and is suitable for comparing categorical 
variables between two or more respondents. Table 6 shows the extent that each set of 
survey respondents reported the same answers to multiple choice questions. 
Table 6 - Krippendorff's alpha agreement per condition 
  Epilepsy Major Depression Narcolepsy 
All Questions 35.54% 28.10% 21.35% 
 
6.2.5 Discussion 
The respondents highlighted several design opportunities as shown in Table 5. Epilepsy 
specialists expressed a need for mental health records that were considered “useful” but 
are often not available to them during patient visits. In addition, respondents from all 
three fields expressed a need for more reliable and frequently collected data. Our findings 
included a need for suicide and depression screening within epilepsy treatment, reliably 
evaluating patient concentration and weight changes for major depression, and driving 
impairment and excessive REM movements when treating patients with narcolepsy. 
The overall consensus among raters within each field was notably lower than expected. 
Table 6 highlights the Krippendorff's alpha agreement between survey respondents; while 
the overall agreement was low there was considerably higher agreement on responses for 
several key symptoms/triggers within each field.  
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Please see our paper titled “Investigating design opportunities for supporting patient self-
reporting within neurocognitive fields” for a more detailed discussion of these findings 
[53].  
6.2.6 Conclusion 
The study produced a set of prioritized clinical information needs and relevant self-
reporting benchmarks during treatment. The results established specific clinical patient 
self-reporting needs during diagnosis and treatment. Moreover, the findings stand to 
improve clinical decision making by clarifying important aspects of self-reporting that 
were not available in the literature (e.g. consistency, promptness, and reliability). 
The research was completed in January 2015 and submitted to CHI in 2017. My study 
was among the first to investigate performance requirements for driving the performance 
requirements for these devices. In addition, I then drew upon these findings to suggest 
design implications for mobile and wearable self-management tools. 
My next two studies, studies #3 and #4, focused on addressing the need for increasing 
data collection quality. The study objectives included evaluating the performance of E4 
seizure detection wristbands and investigating the utility of patient and caregiver video 
review for addressing the problem of over-reporting seizures when using the wristbands. 
6.3 Study #3 - Seizure detection wristband evaluation 
Published - Epilepsia, ‘17 
Onorati, Francesco,...Bidwell, et al. "Multicenter clinical assessment of improved 
wearable multimodal convulsive seizure detectors." Epilepsia 58.11 (2017): 1870-1879. 
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Published - Intech Open Science, ‘17 
Bidwell et al. “Self-reporting technologies for supporting epilepsy treatment”, Intech 
Open Science, Seizures - Chapter, 2017. 
 
My third study investigated the extent to which wearable seizure detection wristbands 
may be able to improve data quality by first asking “To what extent can this seizure 
detection wristband improve the quality of “seizure count” data as compared with self-
report?” and then clarifying “How does the performance of wearable seizure detectors 
compare to current patient self-report for increasing seizure count accuracy?” 
I contacted Empatica’s Chief Scientist, Dr. Rosalind Picard and initiated research to 
evaluate the performance of Empatica’s E4 wristbands in 2014. The E4 had recently been 
released. Dr. Piccard’s company was seeking clinical partners in preparation for FDA 
approval. My colleagues at CHOA and Emory agreed to help evaluate the wristbands in 
exchange for us being able to use them during upcoming studies.  
The relationship was mutually beneficial for two reasons. First Empatica needed ground 
truth vEEG annotations for both evaluating wristband performance and providing labeled 
training examples for further improving performance. Second, I was seeking an 
affordable wearable seizure detection device for my upcoming research; this provided my 
colleagues and me with access to the company’s latest seizure detection devices.  
Moreover, my technology review [33] highlighted that some but not all devices 
performed better than patient self-report. My colleagues and I were interested in 




Many patients have seizures at night that often go unnoticed and therefore unreported. 
Neurologists rely on patients to provide accurate seizure counts during treatment [24]. 
This presents a problem as inaccurate seizure counts can make self-reflection difficult for 
patients and make evaluating medication efficacy difficult for clinicians. It would, 
therefore, be useful to evaluate the performance of new seizure detection devices aimed 
at providing patients and clinicians with more accurate seizure count information.  
In this study, my colleagues and I evaluated the performance of Empatica E4 wristbands 
among pediatric and adult patients. The study included 69 patients who were diagnosed 
with epilepsy and a total of 246 days of recorded wristband measurements among six 
separate epilepsy centers. Hand-annotated video-electroencephalography seizure events 
were collected from 69 patients at six clinical sites. Wrist electrodermal activity and 
accelerometer measurements were concomitantly recorded, obtaining 5,928 hours of data 
(55 recorded events from 22 patients).  
My site at CHOA/Emory contributed data from 32 patients of the overall 69 patients. The 
wristbands successfully detected 52 out of 55 convulsive seizure events and performed 
better than both the prior state-of-the-art and current patient self-reporting capabilities at 
night. The wristbands classified a wide range of motor seizures including generalized 
tonic-clonic (GTC), focal motor (FOCM), secondarily GTC, tonic, myoclonic and clonic 
seizures [123], [124]. In addition, the wristbands collected non-motor EDA [125], [126] 
and peri-ictal autonomic dysregulation [127]–[129] measurements aimed at helping 
clinicians to assess warning signs for Sudden Unexpected Death in Epilepsy (SUDEP) as 
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future work. The main contribution of this study is a performance evaluation to improve 
the state of knowledge regarding wearable seizure detection false positive rates. 
6.3.2 Related work 
Mobile and wearable devices have been proposed for helping patients and caregivers to 
more accurately report seizure events [33]. The key challenge is designing a system that 
is both acceptable for long-term use and can provide clinically relevant information 
during treatment. Electroencephalography (EEG) based systems are the current gold 
standard for detecting, characterizing and diagnosing patient seizures yet these systems 
are bulky, require wearing uncomfortable electrodes on the scalp and are not practical for 
long-term use. Most patients are unable to report seizures while sleeping (85.5%) [24] 
and under report seizures overall (around 50%) [99] (e.g. patients with focal epilepsy that 
have seizures during sleep/wake transitions). Meanwhile, neurologists must rely on 
patient and caregivers to accurately report seizure counts and seizure symptoms between 
appointments yet these reports are known to be inaccurate [30]. For example, more 
objective data collected at home could also help improve physicians’ clinical decisions 
[33], [42] by providing more accurate insights into seizure timing and autonomic 
disruption, for example by observing the amplitude of post-ictal electrodermal activity 
(EDA) surge, a correlate of long-duration PGES following GTC seizures [128]. It is, 
therefore, critical for developing new seizure detection systems that can provide long-
term reporting and alert caregivers in the home. 
Many wearable systems have been proposed for detecting convulsive seizures (CS), but 
most systems report high numbers of false alarms [33], [95], [130] and therefore offer 
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limited utility during treatment. The SmartWatch [70], [131], Epicare Free watch [69], 
[132], Epilert [133] and Brain Sentinel [134] are each sold as commercial products that 
attempt to typically detect seizure events using accelerometry (ACM) [69], [70], [133], 
[135] and electromyogram (EMG) [134], [136] sensors [137], [138]. The challenge is that 
motion and muscle activation measurements during daily behaviors such as tooth 
brushing and exercise often mimic motor manifestations that are associated with CS, and 
systems tend to inflate seizure counts by falsely reporting non-seizure behaviors as 
seizure events. For example, the SmartWatch has reported an average of 204 false alarms 
per day [70] with default settings. This presents a problem as the resulting seizure counts 
tend to be less accurate than patients and clinicians need during treatment [42]. 
Many systems attempt to sidestep this over reporting issue by providing users with an 
adjustable sensitivity setting; however, this is not a principled approach. Increasing the 
sensitivity results in false alarms, while decreasing sensitivity increases the risk of seizure 
events. It is, therefore, important to evaluate the performance of these devices and also to 
assess the extent to which these devices can address clinical data quality needs [139]. 
6.3.3 Methods 
The study included 69 patients with epilepsy. The patients had already been admitted to 
an Epilepsy Monitoring Unit (EMU) and were recruited by a nurse who obtained 
informed consent in accordance with Emory and CHOA Internal Review Board (IRB). 
The patients were instrumented with Empatica E4 wristbands. Hospital staff recorded 
patient video and EEG, and the wristbands recorded wrist acceleration and electrodermal 
activity (EDA) for detecting seizure events.  
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The wristband measurements were uploaded to a server and analyzed separately using a 
modified version of the Poh et al. [140] seizure detection algorithm. Measurements from 
each wristband were analyzed separately within a 10-second sliding window with a 50% 
overlap. Next, a set of statistical features was computed to summarize the EDA and 
accelerometry measurements. These features were sent to a support vector machine 
(SVM) classifier for estimating the probability that a seizure had occurred within each 
window. Each seizure was reported as an onset and duration that included the current 
window and any consecutive adjacent windows with reported seizure activity. 
The study evaluated the performance of two separate seizure detection algorithms that 
each included a set of features and a support vector machine (SVM) as an automated 
classifier for estimating the probability of seizure events. The first algorithm is from Poh 
et al. [140] and well documented. The computed features were evaluated using the 
original SVM classifier from the study. The second algorithm was developed by 
Empatica Inc. Researchers at the company defined additional statistical features and re-
trained the original SVM classifier with additional examples of seizure and non-seizure 
data. These features are proprietary and therefore regrettably cannot be discussed or re-
examined for repeating our results. In each case, the onset timestamp of each event was 
then compared against our ground truth vEEG reference annotations. 
Next, I calculated performance in terms of precision, recall, and F1-score. “Recall or 
sensitivity is the fraction of all seizures that were detected. High recall values reflect a 





(𝑅𝑅𝑅𝑅 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 +  𝑅𝑅𝑅𝑅𝑅 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅)
 
“Precision is the fraction of all relevant seizures that are detected. High precision values 
reflect a low chance of over reporting seizures or triggering false alarms” [33]. 
𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 =
𝑅𝑅𝑅𝑅 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅
(𝑅𝑅𝑅𝑅 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 +  𝑅𝑅𝑅𝑅𝑅 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅)
 
“In both cases, a naive system could achieve perfect recall by reporting ‘true’ at every 
opportunity and likewise achieve perfect precision by reporting ‘false’” [33]. F1-score 
balances over and under reporting are as follows: 
𝑅1 𝑅𝑅𝑅𝑅𝑅 = 2 ∗
(𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 ∗  𝑅𝑅𝑅𝑅𝑅𝑅)
(𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 +  𝑅𝑅𝑅𝑅𝑅𝑅)
 
Most previous studies only report results for patients with seizures (PWS) and only a few 
have presented statistics based on all patients. In our study, I chose to calculate precision 
based on only PWS [33]. It should be noted that including all patients would have been 
preferable to provide more realistic performance. A typical EMU visit ranges 2-5 days, 
however, not all patients have seizures during this time period. In our case, I opted to 
include only PWS in our analysis so that I could compare our results with those from a 
greater number of studies. 
6.3.4 Results 
My colleagues and I collected wristband recorded ACM and EDA data from 69 patients 
who were diagnosed with epilepsy. Inclusion criteria included all English speaking 
pediatric and adult patients with a diagnosis of epilepsy. Informed consent was obtained 
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from all patients and additionally from patient guardians in the case of adult patients with 
developmental delays and pediatric patients.  
The resulting dataset included over 246 days of recording of wristband recorded ACM 
and EDA measurements (5,928 hours, median 22.3 hours per session). EEG technicians 
labeled 55 CS type seizures from 22 patients. The wristbands detected 52 out of 55 CS 
type seizure events. The majority of patients had less than 1 false alarm every 4 days. The 
mean latency of detection was less than 40 seconds for both classifiers. The classifiers 
failed to detect non-CS type seizures; however, no nocturnal seizures were missed among 
patients with CS type seizures. 
The E4 ACM and EDA measurements were analyzed using two separate algorithms for 
comparison. The original seizure detection algorithm from Poh et al. [44] missed few 
seizures but presented frequent false alarms with a recall of 93.8%, a precision of 
34.88%, and with 2.6 false alarms per day. By contrast, a modified version of the Poh 
algorithm performed notably better with a recall of 95.8% and a precision of 51.0% with 
0.2 events per day.  
Table 7 presents a performance comparison of both algorithms alongside prior-art system 
patient self-reporting. The prior-art systems include the studies by Poh et al. [140], 
Beniczky et al. [69] and Schulc et al. [135] as three top-performing systems that are most 
applicable to the proposed Empatica E4 wristband design. Hoppe et al.’s [24] studied 
patient self-reporting capabilities. I referred to analysis from Bidwell et al.’s technology 
review [33] for extrapolating patient self-reporting precision, recall, and F1-score. 
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Table 7 - System and patient self-reporting performance comparison 
Systems F1-score Precision Recall PWS 
Onorati [141] 0.66 0.51 0.95 22 
Poh [140] 0.51 0.35 0.94 7 
Beniczky [69] 0.85 0.81 0.90 20 
Schulc [135] 0.99 0.98 1.0 3 
Patient self-reporting 
Daytime [142] 0.81 1.00 0.68 91 






The study evaluated an improved algorithm that employs ACM and EDA measurements 
for detecting CS among pediatric and adult patients. The improved algorithm can indeed 
increase the quality of “seizure counts” over current, unassisted patients self-reporting at 
night. In Hoppe et al. [24] patients failed to report > 85% of seizures while sleeping and 
patients were assumed to be “perfect reporters” [24] with zero false alarms. The 
wristbands were evaluated during the day and night.  
The results in Table 7 shows that the latest E4 seizure detection wristbands from Onorati 
et. al [141] slightly outperformed the state-of-the-art during our study. The wristbands 
achieved an F1-score of 0.66 while the previous wristband model achieved 0.51 [140].  
The performance also suggests that the wristbands may be better suited for use during at 
night rather than during day. The wristbands performed better than patients at night but 
worse than patients during the day. The wristbands achieved an F1-score of 0.66 for 
reporting seizures during the day and night (seizures detection times were not cataloged 
in our final analysis). This performance is better than patient reporting performance at 
night (F1-score 0.5) but worse than patient reporting during the day (F1-score 0.81). 
The study showed that the E4s performed better than patients for reporting seizures at 
night. In turn, the E4s and similar performing seizure detection devices are well suited for 
measuring seizure frequency at night when patients are less able to report seizures [24]. 
Moreover,  “breakthrough” seizures can occur when a patient’s medication gradually 
loses effectiveness over time. Long-term monitoring of night time seizures could help 
identify “breakthrough” seizures among patients that sleep by themselves, and also 
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provide caregivers with greater peace of mind that loved ones remain seizure free.  
The study also highlighted two notable limitations of current seizure detection devices. 
First, high numbers of false alarms remain problematic. The wristbands were trained to 
provide a near perfect 95.0% recall with a resulting precision of only 51.0%. In the 
future, more work research is needed to discriminate between teeth brushing, dancing and 
other non-seizure behaviors that resulted in false alarms. Second, non-CS type seizures 
were not detected. Most pediatric patients (70%) have focal type seizures [143]; these 
seizures do not necessarily exhibit limb movements. The wristbands failed to detect 
seizures among all patients with nonconvulsive focal seizures with symptoms ranging 
from vocalizations to hand flapping to back arching. More research is needed for 
investigating non-motor patent biomarkers during seizures. In the future, patient-specific 
seizure modeling as proposed by Cuppens et al. [144] may provide a viable path for both 
reducing false alarms and better accounting for differences among seizures with less 
distinct motor movements. 
6.3.5.1 Implications for design 
The study highlighted two design implications for future mobile and wearable self-
management research.  
1. Enrollment was easier than expected within an inpatient EMU setting - Issues 
such as the aesthetics of the devices would likely be much more critical in a patient’s 
typical social setting. The wristbands had minimal decoration. I was informed on several 
occasions that the color, size, and texture of the wristbands looked like “a medical 
device”. In some cases, younger patients only agreed to wear the wristbands after 
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decorating them with stickers. My intuition is that patients may have been more amenable 
towards wearing the wristbands because they were already instrumented with EEG caps 
and had little else to do during the 2-5 day visit. In all, only 2 out of 31 families (6.45%) 
declined to participate when approached. 
2. Instrumenting patients was only possible with caregiver assistance - The caregivers 
were essential for two reasons: getting patients excited about wearing them and helping 
to fasten the wristbands without pinching patients. The wristbands were also made of stiff 
rubber. The stiffness made it difficult to fasten the wristbands without pressing down 
hard on the underside of the wrist. I asked caregivers for help with sensitive patients and 
wrapped the wristbands in soft, adhesive medical bandages as an added precaution for 
reducing skin irritation.  
6.3.6 Conclusion 
My wristband evaluation study investigated the performance and feasibility of using a 
new type of wearable seizure detection wristband for everyday seizure monitoring. This 
study evaluated the performance of the Empatica Inc.’s E4 seizure detection wristbands 
among pediatric and adult patients. The results showed that the E4s has an incremental 
improvement over the state-of-the-art, and the wristbands performed better than patient 
self-reporting at night. E4 wristbands may, therefore, be well suited for seizure counts 
when patients are sleeping and less able to report seizure events. These findings 
contributed to the state of knowledge regarding wearable seizure detection performance 
among pediatric and adult patients. Please refer to Chapter 7 for a more detailed 
discussion of design implications across each of our studies. 
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To publish our findings, my colleagues and I submitted a manuscript to Epilepsia,’17. My 
advisor, Dr. Elizabeth Mynatt and I published a book chapter on our findings in Intech 
Open Science, ‘17. The study shaped my research in two ways. First, I was disappointed 
by the high false alarm rate and poor performance among non-CS seizure types. I have 
since abandoned the prevailing notion that “seizure detection” must be strictly automatic. 
In study #4, I included patients and caregiver in the process of rejecting wristband-
detected false alarms. Second, I was surprised to learn how few resources there were 
beyond seizure detection. In study #5, I propose using the E4 wristbands only at night 
and focusing instead on supporting additional sleep, exercise and mood self-reporting. 
6.4 Study #4 - Rejecting non-seizures from retrospective video of wristband events 
Presented - CHI WISH Workshop, ‘17 
Bidwell, et al. "Rejection of Non-seizures from Retrospective Video of Reported 
Epileptic Seizure Events." Conference for Human-Computer Interaction, WISH 
Conference, 2017 
 
My fourth study investigates a new approach to improving data quality by asking the 
question “To what extent can a patient/caregiver video review of wearable wristband-
detected seizure events further improve the quality of ‘seizure count’ data as compared 
with self-report?”. Rather than of developing another seizure detection device, I instead 
investigated the feasibility of utilizing patient and caregiver video annotations to improve 
data collection quality prior to appointments. 
6.4.1 Summary 
Epilepsy treatment requires accurate patient and caregiver seizure reporting. Neurologists 
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currently must rely on patients and caregivers to accurately document the number of 
seizures that occur between appointments [145], [146]. Many patients and caregivers 
struggle with this task [147], [148], and patient and caregiver seizure reports are known 
to be highly inaccurate [27], [147], [149], [150]. Electroencephalography (EEG) systems 
are not practical for long-term monitoring in the home as special training is required for 
instrumenting patients with scalp electrodes and “reading” or interpreting the EEG 
measurements. Non-EEG mobile and wearable seizure detection systems are now 
available but currently fall short of patient, caregiver and clinician performance 
requirements [33], [42]. The result is that without accurate seizure counts neurologists are 
often unable to determine the effectiveness of medication adjustments for controlling 
seizures. It is, therefore, imperative that researchers investigate new approaches for 
increasing the quality of seizure reporting during treatment.  
The purpose of this study is to investigate a new approach for supporting seizure 
reporting among patients and caregivers. The study included 5 patients. The sample 
included a subset of patients and caregivers that were enrolled in study #3 (4 pediatric 
patients and caregivers from the CHOA and 1 adult patient from Emory University 
Hospital, respectively). In study #3, each patient was instrumented with seizure detection 
wristbands while being video recorded during 2-5 day EMU visits. The wristbands 
recorded the onset times of probable seizure events.  
This study responded to a long-standing need to address a performance gap between 
current seizure detection wristband performance and clinical self-reporting requirements 
during treatment. The participants were asked to annotate video recordings of previously 
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recorded wristband detected events. I investigated the extent that patients and caregivers 
could reject false alarms (e.g. non-seizure related behaviors such as head scratching). 
The main contribution of this work was a new video approach that stands to improve the 
quality of self-reported seizure counts that are available to clinicians. The results showed 
that patients and caregivers were able to correctly reject false alarms and thereby reduce 
the problem of over-reported seizure counts prior to clinical appointments. The approach 
has been shown to accomplish the following: 
1. Enable patients to report seizures that would otherwise be missed, 
2. Require minimal training on the part of patients and caregivers, 
3. Measure seizures events without uncomfortable EEG electrodes,  
4. Increase seizure reporting accuracy beyond current technology limitations and 





6.4.2 Related work  
Neurologists rely on patient and caregiver reported seizure counts for adjusting patient 
meditations. The standard of care is for families maintain a “seizure diary” for logging 
the date, time and a description of seizure events. In practice, most patients and 
caregivers under report seizures while non-EEG seizure detection devices tend to over-
report them. This tradeoff presents two sets of challenges for informing treatment:  
1. Most patients under report seizures - Many patients and caregivers 
struggle with seizure reporting due to impaired consciousness both during and 
following seizure events [99]. Moreover, patients tend to have the most trouble 
reporting seizures at night. In a study from Hoppe et al. [142] more than 85% of adult 
patients failed to report nighttime seizures and reminding patients to fill in reports did 
not improve reporting performance [24]. Eyewitness accounts from caregivers often 
disagree on important seizure reporting details [147], [151] and caregivers are often 
less able to respond to patient seizures at night [152]. It is, therefore, important to 
enable patients and caregivers to review seizures.  
2. Most devices over report seizures - The majority of seizure detection 
devices over report patient seizures [33]. My literature review showed that most 
devices had high false alarm rates and that systems tended to exhibit high recall and 
low precision. For example, Narechania et al. [153] evaluated the MP5 pressure 
sensing mattress and reported a recall of 89.0% and a precision of 43.0% (i.e, 
reporting false alarms rather than missing seizures).  
It is, therefore, important to investigate new approaches that can achieve these clinical 
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performance requirements. If successful, the proposed video review approach could 
increase the accuracy of seizures reporting in the home. 
6.4.3 Methods 
The study was conducted at the Emory University Hospital and Children’s Hospital of 
Atlanta (CHOA) hospitals and included 5 patients (1 adult and 4 pediatric) during 2-5 day 
epilepsy monitoring unit (EMU) visits. The patients each had prior histories of seizures 
were being observed as a part of epilepsy diagnosis or treatment. The video review 
process consisted of the following three steps: 
1. Measuring wristband-detected seizure events - The patients were instrumented 
with Empatica E4 wristbands on the left and right wrists for detecting seizure events 
while being video recorded. The wristbands recorded accelerometry and 
electrodermal activity. These measurements were analyzed offline using a previously 
published seizure detection classifier [140]. The onset time and duration of probable 
seizure events were documented for each patient. 
2. Indexing video of wristband-detected events - The video recordings were then 
indexed or clipped into short segments that spanned +/- 10-seconds before and after 
the onset of each wristband-detected seizure event. Then I randomly indexed up to 
two video clips per day to simulate additional false alarms.  
The wristbands had reported an average of two false alarms per 24 hours in a 
previous study [140]. In practice, the wristbands often reported fewer than two 
seizures per day. Instead of disqualifying patients with low numbers of wristband 
reported seizures I simulated prior performance by randomly indexing up to two 
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additional video clips. Simulating these false alarms guaranteed that each participant 
would review at least two clips per 24 hours of recording and enabled us to further 
investigate how well patients and caregivers could reject false alarms. 
3. Identifying and rejecting false alarms - The study coordinator scheduled a video 
chat meeting following the patient’s visit. The participants jointly reviewed and 
annotated the video clips. This process involved reporting “Yes”, “Maybe” or “No” 
depending on whether the patient appeared to be having a seizure. My colleagues and 
I then calculated seizure count performance for both the video reviewers and E4 
wristbands. EEG technicians had previously hand-annotated the onset and interval of 
seizures using vEEG as a part of the patient’s normal medical treatment. The 
participants’ video review responses were then analyzed to determine the extent that a 
video review might further increase wearable seizure detection performance. 
6.4.4 Data collection 
The hardware selection was intended to provide a similar experience to what they might 
expect when using consumer devices in the home. The patient was video recorded 24/7 
throughout his or her EMU visit. The video was captured using a ceiling mounted Sony 
IPELA EP520 (720 x 480 pixel resolution) installed at the EMU. In addition, an external 
infrared illuminator was located next to the cameras for facilitating video capture at night. 
The resulting video quality was comparable to that of a consumer home security camera 
such as the Foscam FI8918W [154]. The wristbands had a battery life of 36 hours, a data 
storage capacity of 48 hours and recorded ACM and EDA measurements. The wristband 
measurements were uploaded to a server where a previously published seizure detection 
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classifier from Poh et al. [44] was run to detect probable seizure events. 
The video review process was conducted using a screen sharing application called 
TeamViewer Live. The application featured cross-platform support and enabled patients 
and caregivers to speak with the study coordinator and optionally control his mouse and 
keyboard during the video review. 
6.4.5 Results 
The study included 5 patients. My colleagues and I enrolled 4 pediatric patients at CHOA 
and 1 adult patient from Emory University Hospital. The families were enrolled on a 
first-come, first-serve basis during inpatient EMU visits at the respective locations. 
Inclusion criteria included all English speaking pediatric patients with a diagnosis of 
epilepsy along with patient guardians. Informed consent was obtained from all 
participants. In each case, patient guardians were asked whether they would prefer to 
review video with the patients or on the patient’s behalf during enrollment. In addition, 
my colleagues and I obtained informed consent from patient guardians in the case of 
pediatric or adult patients with developmental delays 
The patient population was a subset of the patients that we had enrolled for evaluating the 
E4 seizure detection wristbands in study #3. My original plan had been to include all 32 
patients from this cohort; however, the time-consuming nature of scheduling follow-up 
video calls limited our analysis to 5 of these families. 
The setup time for the video review was between 15-20 minutes and lasted 3 minutes on 




My initial results showed near perfect agreement with our ground truth observations and 
highlights that a patient and caregiver video review can indeed increase the quality of 
wristband-detected seizure counts for addressing clinical performance requirements. The 
video review concept may also be achievable in the short-term for three reasons. 
1. Seizure detection devices tend to over report seizures - Mobile and 
wearable seizure detection systems tend to report high numbers of false alarm rates 
[33]. The participants in the video review were able to identify 100% of false alarms 
to help address this problem. 
2. Patients and caregivers tend to under report seizures - The majority of 
patients have the opposite problem and tend to under report [24]. The use of video 
enables patients and caregivers to see events that they may have missed. Many 
security cameras already have video indexing features [155]. 
3. Hardware and software are affordable and readily available - Finally, 
seizure detection devices and video recording hardware are becoming increasingly 
affordable and therefore may be applicable for extended use for patients at home or 
college. The SAMi Sleep Activity Monitor [156] can already be purchased online. 
In the future clinicians may be able to greatly improve self-reporting seizure reporting 
quality by sending patients and caregivers home with video review hardware for 
dismissing misclassified wristband-detected seizures between appointments. Informal 
interviews conducted following the review suggest that privacy may not be a chief 
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concern among families; two caregivers remarked that they would like to see patient 
seizures at night, and when asked, the patients each said that they would be comfortable 
with having caregivers perform this task on their behalf. 
6.4.7 Conclusion 
This study examined the extent that a patient and caregiver video review can improve the 
quality of seizure counts that are reported using commercially available seizure detection 
wristbands.  
The study employed Empatica E4 seizure detection wristbands and video recording 
during patient EMU visits. The wristbands detected seizures that patients would likely 
have otherwise missed or have been unable to report [24]. The subsequent video review 
enabled patients and caregivers to review video of wristband detected seizure events and 
reject false alarms. The resulting annotations addressed clinical performance 
requirements by rejecting false alarms that would otherwise contribute to over reporting 
and could thereby improve the quality of seizure counts. 
The initial results show that introducing a video review can indeed improve the quality of 
automated seizure counts from a pair of wearable seizure detection wristbands. The 
participants successfully identified and rejected 8 out of 8 false alarms. These findings 
suggest that pairing seizure detection wristbands with additional video capture could help 
to address high false alarm rates among current non-EEG seizure detection devices by 




6.5 Study #5 - Mobile/wearable self-management interventions 
Pending - Epilepsy and Behavior, ‘18 
Bidwell, et al. "Mobile and health tracking pilot interventions for supporting patient and 
caregiver data collection" Epilepsy and Behavior, 2018 (planned submission) 
 
My fifth and final study reflects all three research aims: establishing data collection 
needs, improving data collection quality, and evaluating patient engagement. 
Moreover, how can existing mobile and wearable technologies enable patients and 
caregivers to more consistently, promptly and reliably collect patient health data on 
seizures, sleep, exercise, medication intake, and stress? 
My colleagues and I chose to focus on supporting patient and caregiver self-reporting 
within the context of using mobile and wearable technologies in an effort to address self-
management challenges that are unique to pediatric patients with epilepsy as described in 
chapter 1. The study was designed to help address the following three self-management 
challenges: 
1. Self-regulating patient behaviors - New onset patients with epilepsy need to 
identify and practice effective habits for regulating certain behaviors such as sleep 
and exercise. Mobile and wearable technologies may be able to help summarize and 
present data for increasing patient self-efficacy. 
2. Self-reporting during treatment - Neurologists need access to consistent, prompt, 
and reliable patient health data that families often fail to provide. Mobile and 
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wearable technologies may be able to help facilitate active and passive data 
collection for supporting clinical decision-making. 
3. Increasing self-reliance for adult care - Many adolescents need additional support 
from caregivers as they learn to take on epilepsy self-management responsibilities. 
Mobile and wearable technologies could help to enable greater collaboration during 
this transitional period. 
In this section, I present a mobile EMA study that involves the application of mobile and 
wearable technologies. The study had the following three objectives:  
1. Evaluate feasibility- My first objective is to evaluate the feasibility of mobile EMA 
data collection in terms of consistency, promptness, and reliability between twice 
daily patient and caregiver surveys.  
2. Evaluate approaches - My second objective was to evaluate the positive or negative 
impact of health tracking dashboards, motivational strategies and context-sensitive 
notifications on patient and caregiver self-reporting and patient engagement.  
3. Evaluate experiences - My third objective is to investigate overall patient and 
caregiver user experience. It is important to understand interactions and use cases 
that are compelling or create barriers. In response, we looked at sustained use in the 
field between patients family members and healthcare providers.  
6.5.1 Introduction 
The purpose of this study was to investigate the effectiveness of mobile EMA surveys 
and supporting mobile and wearable technologies within the context of addressing daily 
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needs for pediatric epilepsy treatment.  
Epilepsy treatment relies heavily on patients and caregivers to collect accurate patient 
health data for informing treatment, and many patients and families struggle with these 
daily responsibilities. Meanwhile, pediatric patients must learn how to manage and self-
regulate behaviors in preparation for adult care and successful self-management. Mobile 
EMA surveys can be administered on smartphones, and evidence among adult patients 
suggests that these types of surveys may be helpful for informing epilepsy treatment [20]. 
Mobile and wearable technologies stand to further enhance mobile EMA effectiveness. 
However, research into the applicability of these benefits and attempts to adapt current 
mobile and wearable technologies for daily self-reporting among pediatric patients with 
epilepsy has been limited [30], [42]. Mobile smartphones are accessible, and most 
adolescents and caregivers do not require specialized training for tasks such as creating 
an account with a user profile for storing data.  
As a pilot study, my key results centered on identifying when and how families 
responded to regular survey requests and establishing the feasibility of using this 
information to inform clinical care.  
My findings included establishing existing data collection practices among patients and 
caregivers, evaluating the feasibility and performance of using mobile EMA and health 
tracking interventions to report patient health information and further evaluating impact 
of these interventions on patient engagement. Finally, an additional contribution of this 
work are design implications in Chapter 7 with the aim of informing the development of 
future self-reporting and management tools.  
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6.5.2 Related work 
Medical literature and clinicians agree that patient reported seizure counts, medication 
adherence, sleep quality, mood, and sudden changes in exercise are important to consider 
when making medication adjustments [53]. However, there is limited guidance available 
regarding what health data families should collect and how often it should be collected. 
The most consistent requirements can be found in seizure reporting forms such as the 
Epilepsy Foundation, Seizure Observation Record [157] and include reporting time, 
number and duration of seizures. 
Electronic seizure diaries are thought to reduce the overhead of keeping track of paper 
reports when patients and family members are attempting to document seizures and 
seizure triggers [158]. However, many patients struggle to report seizure events [15], 
[159]. Studies show that family and friends often disagree on important details when 
observing seizures [160], and diary techniques are known to be susceptible to response 
bias when information is entered after the fact [158].  
Mobile phone EMA studies have become increasingly popular in recent years due to the 
widespread prevalence of smartphones [161], [162]. However, the clinical impacts of 
these studies are often limited due to short deployment periods or small numbers of 
participants [163]–[165]. EMA is a research method in which participants complete short 
sets of survey questions “in the moment” rather than responding to a longer survey at a 
later point in time [166]. Haut et al. [63] received high EMA response rates among adult 
patients with epilepsy, but the study did not include pediatric patients. 
Mobile and wearable applications may also stand to improve mobile EMA effectiveness. 
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The introduction of context-sensitive notifications, health tracking dashboards, and 
motivational strategies have each been shown to be effective for supporting aspects of 
self-management among patients with chronic conditions.  
1. Context sensitive notifications - “Blood glucose, spirometry, adherence (e.g. the 
number of cigarettes/pills), blood pressure, weight, physical activity, mental state, side 
effects” can now be documented using mobile phones [167]. Kaushik et al. [168] have 
shown that context-sensitive medication reminders can be more effective than traditional 
reminders that are scheduled at predefined times. Moreover, while Arsand et al. [71] 
have recommended similar types of reminders for pediatric patients with diabetes, 
context sensitive notifications have yet to be explored within the scope of epilepsy self-
reporting and self-management. 
2. Health tracking and dashboards - Health tracking and dashboards have also been 
shown to help patients with self-regulation. Guendelman et al. [169] showed that asthma 
diaries can significantly increase self-management indicators. Electronic seizure diaries 
have been explored within the context of pediatric epilepsy [30], but specific data 
collection needs were not studied. Moreover, studies suggest that self-reporting can 
increase patient self-efficacy [170]; however, more work is needed to assess trade-offs 
between active and passive data collection approaches among patients and caregivers. 
3. Motivational strategies - Intrinsic and extrinsic motivational strategies can 
encourage pediatric patients with chronic conditions to perform similar daily self-
management tasks such as patient-specific goal setting within the context of diabetes 
management [71] and external incentives, “pay for performance” incentives in the case 
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of childhood asthma management with outcome measures such as reduced “missed 
school days, missed workdays, and parent or patient confidence” [171]. Motivational 
strategies have been shown to be effective in other fields but have not been well 
explored in pediatric epilepsy treatment. 
It would, therefore, be beneficial to investigate mobile and wearable interventions for 
supporting pediatric epilepsy self-reporting and self-management. In this study, I 
investigated the use of manual (active) data collection via mobile surveys and automated 
(passive) data collection approaches using health tracking devices. 
6.5.3 Methods 
The study included 30 families. The families were asked to complete EMA surveys using 
a mobile app for 30 days, and they were then randomly assigned to one of three 
conditions during enrollment. The survey questions reported on five topics that are 
important for epilepsy treatment: patient seizure counts, medication adherence, mood, 
sleep quality and exercise data. The participants each received daily reminders and 
notifications to complete surveys. To increase self-reporting accountability, I instructed 
the families that a clinician would review the data once per week. In practice, the 
clinician only reviewed a subset of families. Each family received a $20 gift card upon 
completing the study. 
The study included three conditions: a baseline control and two experimental conditions. 
Each study condition included 10 families and shared a number of common sets of study 
components and outcomes measures. The experimental conditions each included the 
same mobile EMA surveys, clinical audience, and outcome measures as the baseline 
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condition but provided families with additional resources as shown in Table 8. 
Table 8 - Main study experimental conditions 
 
The research was informed by a 15 family pilot for the baseline and experimental 
conditions. The remainder of this chapter elaborates on each study condition in more 
detail. The following are key lessons that I learned from our pilot study: 
● Importance of a single app - For the pilot, we used bookmarks for online surveys but 
we learned the importance of having an app-type environment for ease of usage.  
● Higher response rates among patients than caregivers - The patients were more likely 
than caregivers to continue self-reporting. No caregivers reported for the entire 30 
day study period; while three patients reported for all 30 days. 
● High drop-out rates were common during the initial phases of the study. Most 
participants did not complete self-reports after the first week of the study.  
● Early adopters and champions - Identifying and working with a core group of beta-
 
80 
testers were useful for addressing initial problems with the app such as daily 
reminders that were issued too frequently by accident. 
6.5.3.1 Baseline Study Condition 
Mobile and wearable devices are becoming increasingly capable of measuring many of 
the same behaviors that patients and caregivers are already asked to document as a part of 
“seizure diaries” [30].          
The baseline study condition included 10 families and evaluated the feasibility of patients 
and caregivers using mobile EMA surveys to collect patient health information over 30 
days. The surveys were administered daily, weekly, and following patient seizures 
events. The surveys documented five aspects of patient health: seizures, medication 
adherence, sleep, mood, and exercise. We selected these categories to reflect behaviors 
that patients and caregivers are already asked to actively report as a part of “seizure 
diaries” [30] and also could be passively reported using mobile and health tracking 
devices. I analyzed the responses to evaluate data collection practices, self-reporting 





6.5.3.1.1 Mobile EMA component 
My colleagues and I developed a mobile app called EpiSense for administering mobile 
EMA surveys, sending reminders and reviewing patient data as shown in Table 9.  
Table 9 - EpiSense mobile EMA app/hardware components
 
The app was designed to investigate the feasibility of patients and caregiver self-reporting 
and provide a platform for evaluating subsequent experimental interventions. 
6.5.3.1.1.1. Surveys 
The participants were asked to complete four types of surveys with separate sets of 
questions for patients and caregivers, respectively. The app administered intake and exit 
surveys at the start and end of the study, daily and weekly surveys and event-contingent 




The daily and weekly surveys collected information on patient seizures, medication 
adherence, sleep, exercise, mood, and location. The intake and exit surveys collected 
demographic information and patient engagement information. I reviewed and edited 
each set of questions with clinicians for feedback on response burden and question 
coverage. Each survey took 1-5 minutes for participants to complete. The total time 
commitment was estimated at 7-15 minutes per week.  
The surveys included questions from 13 short-form instruments as shown in Table 10 and 
Table 11. I selected surveys that were both age and reading-level appropriate and also 
had been validated in extant research.  
For example, the following three questions were selected from the Self-Efficacy for 
Managing Chronic Disease 6-item Scale (SEM-CD) [78] (questions 4-6): 
1. How confident do you feel that you can keep any other symptoms or health 
problems you have from interfering with the things you want to do? (4) 
2. How confident do you feel that you can the different tasks and activities needed to 
manage your health condition so as to reduce your need to see a doctor? (5) 
3. How confident do you feel that you can do things other than just taking 




Table 10 - Intake and Exit mobile EMA survey categories and instruments 
Instruments Intake Survey Exit Survey 
 Patient Caregiver Patient Caregiver 
General     
Demographics  3  3 
Data collection practices 3  3  
Self-efficacy     
Self-Efficacy for Managing Chronic Disease 6-item 
Scale (SEM-CD) [78] 
3  3  
Activation     
Patient Activation Measure (PAM) [79] 13  13  
Seizures     
Adult Epilepsy Self-Management Measurement 
Instrument (AESMMI) [172] 
2 2 2 2 
Epilepsy Foundation [157], [173] 2 2 2 2 
Medication     
Adult Epilepsy Self-Management Measurement 
Instrument (AESMMI) [172] 
1  1  
Sleep     
Adult Epilepsy Self-Management Measurement 
Instrument (AESMMI) [172] 
1  1  
Medical Center Sleep Center [174] 1 1 1  
Mood     
Patient-Reported Outcomes Measurement Information 
System (PROMIS) [175] 
 1  1 
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Spence Children’s Anxiety Scale (SCAS) [176], [177] 1  1  
Adult Epilepsy Self-Management Measurement 
Instrument (AESMMI) [172] 
2  2  
Exercise     
Adult Epilepsy Self-Management Measurement 
Instrument (AESMMI) [172] 
1 1 1 1 
 
Table 11 - Morning and weekly mobile EMA survey categories and instruments 
Instruments Daily Survey Weekly Survey 
 Patient Caregiver Patient Caregiver 
Seizures     
Epilepsy Foundation [157], [173] 2   2 
Medication     
Morisky Medication Adherence Scales 8 (MMAS-8) 
[178] 
1 1 1 1 
Sleep     
Pittsburgh Sleep Diary (PghSD) [179] 2 2   
Children’s Sleep Habits Questionnaire (CSHQ) [180]  1  1 
Adult Epilepsy Self-Management Measurement 
Instrument (AESMMI) [172] 
  1  
Mood     
Patient-Reported Outcomes Measurement Information 
System (PROMIS) [175] 
2 4 2 4 
How I Feel Chart TKG Inc [181] 1    
Exercise     
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CDC Middle School Youth Risk Behavior Survey [182] 4 4 3 3 
 
The majority of questions could be adopted verbatim with no changes in wording from 
the original survey instruments. I adapted several questions to clarify either the response 
interval (e.g. adding “in the last week” to questions) or the relationship between the 
participants (e.g. adding “your child” to questions to caregiver directed questions). 
6.5.3.1.1.2. Reminders 
The participants received reminders to complete daily survey instruments. The reminders 
were displayed as native in-app notifications on the participants’ phone. The mechanics 
of reminders differed between study conditions. “Baseline” condition reminders followed 
a predefined schedule. The EpiSense app checked for survey completion every 5 minutes 
and triggered up to two notifications per day. By contrast, “health tracking dashboard” 
and “motivational strategies” condition reminders also checked for survey completion but 
triggered when the patient and caregiver were in close proximity as shown in Table 12. 






The reminders were sent according to the following schedule to accommodate typical 
school routines: 
1. Intake and exit survey reminders were sent once per night at 8 pm 
2. Morning and evening reminders were sent at 7 am and 8 pm, respectively 
3. Weekly reminders were similarly be sent at 8 pm. 
6.5.3.1.1.3. Clinical Audience 
My informal interviews suggested that many caregivers perceived self-reporting as the 
patient’s responsibility. The study included a nurse practitioner who reviewed patient and 
caregiver data once per week.  
The nurse practitioner served as a “clinical audience” with the goal of further increasing 
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accountability and motivating caregivers to participate (i.e.collecting data could benefit 
your child’s treatment). The EpiSense app included a clinical dashboard for reviewing 
patient and caregiver collected data during the study. The dashboard featured a timeline 
summary of seizure counts, medication adherence, mood, sleep quality and exercise data 
along with descriptive statistics as shown in Table 13. 
 
Table 13 - EpiSense clinical dashboard showing patient and caregiver collected 
data (Top-left) list of patients, (Top-right) clinical settings for maximum and 






6.5.3.1.1.4. Software Architecture 
The EpisSense app used the HIPPA compliant CHOA Redcap service to ensure that 
collected mobile phone survey responses and collected data remained confidential during 
the study. The Auth0 authentication platform was used for managing user login and 
passwords. Native SQLite was used for local data storage. The Redcap API was used as a 
remote storage platform. The participants’ data was formatted as JSON files, encrypted 
and uploaded to Redcap as a file attachment each day as shown in Table 14. 
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Table 14 - EpiSense and Redcap software architecture diagram 
 
6.5.3.2 Experimental Conditions 
The study included the following two experimental conditions: 1) a health tracking 
dashboard and 2) motivational strategies. In each case, the participants were asked to 
complete the same mobile EMA surveys using the app but received additional resources. 
The relative impact of each condition was evaluated by comparing self-reporting and 
patient engagement outcomes against those from the baseline condition. 
6.5.3.2.1 Health tracking dashboard 
Health tracking devices were issued to patients and caregivers with the goal of 
encouraging patients’ self-reflection and self-regulation. The devices measured patient 
medication adherence, sleep, exercise and helped to coordinate daily survey reminders. 
The EpiSense app presented this information on a health tracking dashboard that could be 
accessed “on-demand” during the study. 
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6.5.3.2.2 Motivational Strategies 
Health trackers and an additional financial incentive were issued to participants for 
encouraging patients to complete a daily personal health goal. The patients set a health 
goal at the start of the study and received $5 a day in credit each time they completed the 
goal. The health tracking devices were used to assess whether or not patients achieved the 
goal (e.g. Fitbit sleep duration was used to assess the goal “get at least 8 hours of sleep 
each night”).  
In addition, the health tracking data were collected and compared against the patient and 
caregiver mobile EMA survey responses for an additional perspective on the reliability of 
patient self-reports (e.g. device reported sleep duration vs. self-reported sleep duration)." 
6.5.3.3 Enrollment 
The study included 30 families of patients with epilepsy at CHOA. The families were 
enrolled on a first-come, first-serve basis at the CHOA North Druid Hills outpatient 
clinic. Inclusion criteria included all families that have a child being treated for epilepsy 
at CHOA between the ages of 10-18 years old with access to an Android or iOS 
smartphone. The patient and caregiver had to own a smartphone. Exclusion criteria 
included non-English speaking participants and patients with severe intellectual disability 
and whose caregiver deemed that they would not be capable of completing daily surveys. 
The families were enrolled following outpatient appointments. The nurse practitioner 
introduced them to an onsite study coordinator from Georgia Tech. The study coordinator 
then enrolled families and walked participants through installing the app and using any 
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applicable health tracking devices as summarized in Table 9. 
My colleagues and I elected to enroll at least 30 families to provide a representative 
patient population. The clinic admitted an average of 40-85 patients per week, and 
epilepsy specialists see 10-50 families per week. The patients reflected a range of 
socioeconomic backgrounds, levels of education, and types of epilepsy. I enrolled a total 
of 48 families at a rate of 1-4 patients per week over a period of 18 months. 15 families 
were recruited as beta-testers for the EpiSense app and were not included in the analysis. 
33 families were recruited for the study. 3 of these 33 families either did not follow 
through with installing the app or had other technical difficulties such as out of date 
Android devices that prevented them from completing daily surveys.  
6.5.3.4 Outcome Measures 
My colleagues and I evaluated data collection practices, self-reporting performance and 




6.5.3.4.1 Data collection practices 
Intake and exit surveys were administered during study enrollment and completion. The 
surveys included questions on participant demographics and data collection practices. 
6.5.3.4.2 Self-reporting performance 
Self-reporting performance was assessed in terms of the consistency, promptness, and 
reliability of completing daily and weekly surveys. The surveys included questions on 
seizures, medication, sleep, exercise, mood, and location. 
Self-reporting reliability was evaluated in terms of the percent agreement between 
patients and caregivers.  Table 15 shows the agreement criteria that we used for between 
patients, caregivers, and devices.  
Table 15 - Reliability - Agreement criteria for measuring consensus between 
patients, caregivers, and health tracking devices 
Data Type Agreement Criteria 
Seizures Both respondents report the same number of patient seizure on a given date 
Medication Both respondents agree that a patient did or did not take his or her medications 
Sleep Respondents report sleep duration reports within +/- 1 hour of one another 
Exercise Both respondents agree that a patient exercised for at least 60 minutes 
Mood 
Both respondents report that a patient’s mood is either above or below 75 on a 
continuous mood scale between 0-100 
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6.5.3.4.3 Patient engagement 
The intake and exit surveys also measured patient engagement. The patients were asked 
to complete three questions from the Self-Efficacy for Managing Chronic Disease 6-item 
Scale (SEM-CD) [78] and the entire thirteen question PAM [79]. I calculated the relative 
change between these scores at intake and exit to assess the extent that each study 
condition may be able to improve patient self-efficacy and activation. 
6.5.3.5 Data collection 
The study collected intake and exit surveys, mobile contextual information, mobile EMA 
surveys, caregiver proximity information, and passive health tracking measurements.  
The following list describes each of these data collection instruments in more detail: 
1. Intake surveys - The participants each completed intake survey responses for 
establishing demographics, data collection practices. In addition, all patients were 
asked to complete the SEM-CD and PAM for assessing self-efficacy, and activation; 
“motivational strategies” patients were asked to select a personal health goal. 
2. Exit surveys - The participants were also asked to complete an exit survey. The exit 
survey included the same set of intake survey questions on data collection practices, 
patient self-efficacy, and activation along with additional user experience questions. 
3. Mobile app usage - The EpiSense app also collected patient and caregiver proximity 
and app usage information. This contextual information was sampled every hour and 
additionally each time the participants submitted a survey response. Finally, the app 
enabled participants in the “motivational strategies” condition to track whether or not 
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patients completed daily health goals. 
4. Daily survey responses - The participants completed once daily, once weekly and 
event contingent mobile EMA surveys as previously described. The EpiSense app 
collected these responses to support treatment in the areas of seizure management, 
medication adherence, mood, sleep, and exercise. 
5. Health tracking device data - The patients in the “health tracking dashboard” and 
“motivational strategies” conditions received additional health tracking devices that 
included a Fitbit Charge 2 and morning and evening Tricella pillboxes. Information 
from these devices was displayed on a patient health dashboard.  
6. Health activity/fitness tracker - The patient were instructed to wear the Fitbit 
Charge 2 during the study for tracking daily exercise, sleep, and mood. A sedentary 
lifestyle can increase the risk of seizures. The Fitbit tracked step count and duration 
of moderate to intense exercise each day. 
7. Caregiver proximity tag - The caregivers in the “health tracking dashboard” and 
“motivational strategies” conditions received an additional Bluetooth tag and a credit 
card sized insert that adhered to the back of his or her phone to carry the device. The 
patient’s app paired with the tag to facilitate survey reminders when the Bluetooth tag 
came within range. The Received Signal Strength Indicator (RSSI) was measured 
every 2 minutes with the aim of triggering notifications when patients and caregivers 
were both nearby for encouraging discussion and peer support between participants. 
8. Medication adherence pillboxes - Each family also received two Tricella pill boxes 
for measuring morning and evening medication intake. Most patients take morning 
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and evening medications at home. Medication is typically administered by a nurse at 
school. The pillboxes recorded the time that drawers were opened and closed to 
remove medication and sent this information to the patient’s phone via Bluetooth. 
6.5.3.6 Analysis 
My analysis had the following three objectives: 
1. Evaluate feasibility and efficacy - The first objective was to identify positive aspects 
of user experiences based on daily data collection practices and technology usage 
within each condition. I began by computing descriptive statistics on data collection 
practices and technology usage to better understand existing participant self-reporting 
practices. I then analyzed self-reporting performance to highlight opportunities for 
improving data quality. Finally, I compared patient self-efficacy and PAM scores 
between each study condition as an indicator of patient engagement. 
2. Evaluate experimental conditions - The second objective was to identify study 
conditions that increased self-reporting performance metrics and improved patient 
engagement. In each study condition, I evaluated and compared 1) data collection 
practices, 2) self-reporting performance metrics, and 3) patient engagement scores. 
3. Evaluate the context of use - The third objective was to identify conditions that 
increase patient self-efficacy and PAM scores as compared with study outcomes from 
patients in the “baseline” condition. 
 6.5.4 Results and Discussion 
The study was conducted in two phases: a testing phase and a production phase. Please 
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see Appendix C for more detailed family-by-family self-reporting comparisons. 
1. Testing Phase - The testing phase included field testing mobile surveys during a 4 
month evaluation period. I enrolled 15 families as beta-testers. Low response rates 
prompted me to make a number of changes such as reducing the frequency of 
surveys from twice daily to once daily and reducing the number of questions overall. 
The low response rate also motivated the experimental condition with motivational 
incentives. 
2. Production Phase - The production phase occurred during the next 20 months. I 
recruited 33 families and made considerable refinements to the app including adding 
support for context sensitive notifications, integration with health tracking devices, 
summarizing health information on a mobile dashboard, and enabling patients to 
monitor the completion of daily health goals. 
The remainder of this chapter will only refer to results from the production phase due to 





In the final study, the patients were age 10-15 (Mean, 11.2, SD 4.31), primarily female 
60.0% (male 40.0% and prefer not to disclose 0.0%), and split equally between races 
white and black (white 50.0%, black 50.0% and Asian/Pacific Islander 0.0%). Neary all 
patients were enrolled in elementary school at the time of the study, 80.0% (80% 
elementary school and 20.0% high school). Most patients had well controlled epilepsy. 
The average time since diagnosis varied between 0-5 years (Mean 2.0, SD 1.9 years). The 
majority of caregivers reported that patients had been seizure free for at least 5 months 
prior to enrollment (Mean 5.94 months, SD 8.88 months). 
The caregivers tended to be college educated (30.0% high school, some college 20.0%, 
50% college and 20.0% college or above), female 90.0% (male 10.0%) and of white race 
50.0% (black 50.0% and Asian/Pacific islander 0.0%). 
The nurse practitioner had 5 years of experience prescribing medications and worked 
full-time at CHOA. Her schedule included an estimated 160 average of hours of direct 
patient care per month at the time of the study. 
6.5.4.2. Data collection practices 
Intake surveys were used to establish baseline measures on self-reporting behaviors. 
Table 16 shows the percentage of all participants that reported they were already 
collecting patient data prior to the study along with the method used for data collection.  
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Table 16 - Historic self-report of data collection practices 
 
 
6.5.4.3. Self-reporting performance metrics 
This section will present the consistency, promptness, and reliability of self-reporting 
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among patients and caregivers. My colleagues and I encountered two sets of challenges 
that impacted our evaluation approach. 
1. Many participants did not engage beyond completing the initial intake 
survey. In response, results will be presented twice: once in terms of all 
participants and once in terms of only those participants who reported data past 
study day 5 of 30. 
2. Many families did not collect data past the first week of the study. In 
response, results will similarly be presented twice: once in terms of all 
participants and once in terms of only those participants that continued reporting 
past the first week of the study (i.e. past day 5 of 30). 
3. Most patients did not report exit surveys. In turn, patient engagement will be 
discussed in terms of patient case studies rather than descriptive statistics due to 
the low number of intake and exit survey responses. 13 patients completed the 
intake survey; only 2 patients completed the exit survey. 
6.5.5.1. Data collection practices 
This section investigates current patient and caregiver data collection practices. Intake 
surveys responses in Table 16 show that all caregivers (10 out of 10 caregivers) and most 
patients (12 out of 14 patients) responded that they reported seizure frequency (i.e. how 
often seizures occurred). In addition, while most patients did not regularly keep track of 
seizures, patients preferred electronic tools. This suggests that patients may be good 
candidates for using mobile apps for self-management purposes. 
Internet connectivity and the popularity of electronic seizure diaries among patients 
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suggest that a mobile platform may be well suited for patients and caregivers. The 
patients tended to use electronic data collection tools (5 out of 14 patients) over paper 
diaries and alternative methods (4 out of 14 patients and 4 out of 14 patients). Nearly all 
participants had access to the internet. In one case, a patient had an older Android tablet 
that was unable to connect to the internet via wifi. The caregivers had a mix of Android 
and iOS smartphones with monthly data plans. The patients had similar smartphones but 
less consistent internet access. Most patients relied on wifi for for downloading the app 
during enrollment while others had data plans. The EpiSense app supported offline 
access. Internet connectivity did not appear to be an issue for us during the study. 
6.5.5.2. Self-reporting performance metrics 
This section investigates how can mobile interventions help patients and caregivers to 
more consistently and reliability collect clinically relevant health data during treatment. 
6.5.5.2.1 Consistency 
The consistency of patient and caregiver self-reports is important for attributing cause 
and effect between patient health behaviors and seizure frequency. Most of the families in 
our study struggled to consistently collect data; however, families in the experimental 
conditions were able to collect data much more regularly.  
The participants tended to fall into one of two groups: those that reported for the entirety 
of the study and those that stopped reporting following enrollment or after the first week. 
Non-starters were most frequent among families in the baseline condition with 7 of 16 
families not completing any surveys and all families from the experimental conditions 
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completing at least one survey. In Appendix C, we can see that roughly one third of 
participants (11 families, 36.66%) stopped collecting data after 1 week (5 of 30 days).  
In addition, self-reporting tended to be the most consistent among families of patients that 
had frequent seizures. In Appendix C,we can see that patients from families 4 and 24 
reported seizures. These families reported more consistently than families 12 and 32 that 
were in the same study condition but were patients did not report having seizures. 
Interestingly, we did not observe a causal relationship between the date of patient seizure 
events and the subsequent consistency of self-reporting. For example, there was no 
noticeable uptick in overall self-reporting frequency in the days following seizure events. 
6.5.5.2.2 Promptness 
The promptness of self-reporting is important to consider for anticipating recall bias. In 
the past, studies have studied the consistency of patient reporting but not the promptness 
of reporting [56]. In our case, participants received up to two daily reminders to complete 
daily and weekly surveys at 7 am. The average time delay or latency between the 7 am 
target time and participant responses was 9.38 minutes after the first reminder (SD 6.27 
minutes) among all study conditions.  
Introducing patient-caregiver proximity reminders appears to have had an impact on 
promptness in the experimental conditions. The promptness of participant reporting is 
shown in Appendix C. The average latency was highest among participants in the 
“baseline” study condition at 12.67 minutes followed by “health tracking” at 7.46 




The reliability of self-reporting is another important consideration given the absence of 
traditional ground truth measurements for certain daily survey questions. In this case, we 
measured pairwise inter-rater reliability between patients, caregivers and devices reports 
on patient seizures, medication intake, sleep, mood and exercise as shown in Appendix C. 
In some cases, the generalizability of our results are limited by the number of families 
that reported data on the same dates. My colleagues and I rarely received self-reports 
from both sets of participants on the same dates. Instead, a single engaged patient or a 
single caregiver tended to provide most of the self-reports. For example, in Appendix C 
we can see that patients but not caregivers regularly reported submitted daily surveys in 
families 1, 6 and 26. By contrast, caregivers but not patients regularly reported  in 
families 8, 23 and 31. In response, I will present individual case studies to investigate the 
question “when patients and caregivers reported data, what did they agree and when did 
they disagree?”. 
Table 17, shows percent agreement between patients and caregivers given study dates 
when both the patient and caregiver submitted daily surveys on the same study dates. The 
highest agreement was on seizures at 89.89% followed by sleep at 49.07%. Medication 
intake and and exercise appear to be more difficult for both participants to observe at 
32.89% and 14.29%, respectively. In addition, Table 18 presents percent agreement 
between study conditions in terms of five levels of agreement: “None” for no agreement 
(0%), “slightly” (1-25%), “moderate” (26-50%), “agree” (51-75%) and “strongly agree” 
(76-100%). It should be noted that no seizures occurred during the baseline condition. No 
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agreement was present among respective medication and sleep reports. This disagreement 
could be due to “false” being the default response when respondents skipped questions.  
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Table 17 - Reliability - Percent agreement between patient and caregiver. (Top) 
Daily self-reporting among all families. (Bottom) Daily self-reporting among 






Table 18 - Reliability levels by study condition 
 Study Condition Data Type     
#  Seizures Medication Sleep Exercise Mood 
1 Baseline None Strongly Moderate Moderate Moderate 




Strongly None Moderate None Moderate 
6.5.5.3. Patient Engagement 
This section investigates the effectiveness of mobile interventions for increasing patient 
engagement. Intake and exit patient SEM-CD and PAM scores showed a slight 
improvement for patient 65 in the “motivational strategies” condition with a change of 
48.00 and 29.90, respectively. By contrast, patient 27 from the “baseline” condition had a 
slide degrease with a change of  -119 and -7.41, respectively.  
This initial decrease in PAM could be due to patients discovering the need to better 
manage symptoms. In a study from Disabato et al. [183]; patients experienced a similar 
decrease in PAM following an intervention. It follows that a a short-term decrease in 




6.5.4.4. Self-efficacy and activation scores 
The intake and exit surveys included the SEM-CD and PAM instruments for measuring 
changes in patient engagement. In practice, we only received 2 out of 30 patient exit 
surveys thereby limiting our ability to make direct comparisons on patient engagement 
measures. In response, we will only present patient case studies where both intake and 
exit surveys are available.  
Table X and Table 20 shows the mean SEM-CD and PAM scores during the intake 
surveys. The charts show 5 sets of SEM-CD and PAM survey responses from patients in 
the “baseline” condition, 5 from patients in the “health tracking dashboard” condition and 
2 sets of responses from patients in the “motivational strategies” condition. 
Table 21 shows survey results for two specific patients where we had both intake and exit 
surveys. The results suggest that patient engagement may decrease for patients in the 
“baseline” condition and increase for the “motivational strategies” condition.  
The SEM-CD and PAM scores both decreased for patient 27 in the “baseline condition”. 
It could be that self-reporting causes some patients to recalibrate their previously held 
health beliefs. In the short term, patient engagement may decrease as patients realize the 
need to develop certain aspects of self-management. By contrast, SEM-CD and PAM 
scores both increased in the case of patient 65 in the “motivational strategies” condition. 
It could be that goal setting and financial incentives motivate certain patients to address 
long-standing self-management issues. 















This study investigated the feasibility and effectiveness of mobile EMA surveys and 
mobile and wearable technologies within the context of addressing daily needs for 
pediatric epilepsy treatment.  
My colleagues and I administered mobile EMA surveys among pediatric patients and 
caregivers to collect daily information for informing epilepsy treatment and improving 
patient self-efficacy and activation. In addition, I investigated the role that introducing 
additional health tracking, a health tracking dashboard and motivational strategies could 
play in further improving the consistency, promptness and reliability of EMA surveys. 
For example, patients and devices are likely best for collecting mood and exercise data 
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while caregivers are likely best at collecting seizures, medication intake and sleep. 
The results among families that continued reporting past the first week of the study 
highlighted three important findings.  
1. Mobile EMA may be well suited for patients. Most patients that report seizures 
keep track of them using an electronic method (e.g. tablet, website). 
2. Mobile EMA is feasible for collecting daily patient and caregiver self-reports. The 
EpiSense app enabled participants to successfully complete health daily surveys.  
3. Motivational strategies are important for engagement. Initial case studies suggest 
that enabling patients to select a health goal and receive daily financial incentives 
can increase patient SEM-CD and PAM scores. 
Mobile EMA interventions can therefore play a role in supporting patients and caregiver 
data collection and patient self-management between clinical appointments. In addition, 
more research is needed for engaging families, incentivizing daily patient and caregiver 




CHAPTER 7. IMPLICATIONS FOR DESIGN 
The following is a summary of our findings to serve as guidelines for developing future 
pediatric self-management tools. This section consolidates our findings from studies 1-5 
and highlights additional design insights from our conversations during enrollment. 
These design insights include approaches for addressing data collection needs, improving 
data collection quality in terms of consistent, prompt and reliable patient and caregiver 
data collection, and increasing patient self-efficacy and PAM scores.  
7.1 Establishing Data Collection Needs 
The first set of design implications were derived from patient, caregiver and clinician 
self-reporting and self-management needs. These design implications include prioritizing 
self-reporting to reflect patient priorities such as reporting mood while at school as well 
as recommending technology interventions that address social stigma considerations. 
It would be beneficial to prioritize additional information on standard seizure reporting 
forms. Mental health and sleep related responses could be highly beneficial for clinicians. 
In addition, not all information has to be entered by the patient as discussed in study #2. 
The PedsQL [184] is an excellent example of a short form survey that captures relevant 
psychological information during treatment. In our local area, researchers at CHOA are 
considering the use of several mental health screeners during outpatient research studies. 
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7.2 Improving Data Collection Quality 
The second set of design implications focused on the extent to which mobile and 
wearable devices and incentives can improve data quality. The following are six 
recommendations that draw from our research for improving data quality:  
1. Navigating data collection roles - Minimizing the response burden is a must for 
long-term data collection. It is therefore important to choose the best person or device 
for collecting specific types of information. Health tracking devices agreed well with 
self-reported exercise, medication intake and sleep. It may therefore be helpful to 
focus or limit “active” patient data collection to mood, focus caregiver efforts on 
documenting seizures and focus “passive” health tracking data collection devices on 
the remaining areas of exercise, medication intake and sleep, respectively. 
2. Reviewing nighttime seizure reports - In study #4, I showed that patients and 
caregivers can greatly reduce false positives given video of wristband detected 
seizure events. It may, therefore, be helpful to incorporate an additional video review 
for reducing false alarms when using seizure detection wristbands. 
3. Implementing motivational strategies for consistent and prompt data collection - 
It is also important that data collection be both consistent and prompt for informing 
treatment and identifying successful self-management strategies. In study #5, we 
found that the “motivational strategies” condition increased engagement. It may 
therefore be helpful to apply similar incentives at the onset of an intervention for 
establishing a baseline of patient and caregiver self-reports and passive sensing 
reported measures. For example, patient reported sleep duration may have a 
systematic bias and tend to be reported one our earlier than Fitbit reported sleep 
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duration. Then passive health tracking measures could supplement or replace patient 
and caregiver self-reporting after this initial motivational incentives stage. 
4. Encouraging reliable data collection among families - It is important for clinicians 
to be able to rely on self-reported data collection. In study #5, my colleagues and I 
experimented with traditional reminders and patient-caregiver proximity reminders. 
Informal conversations with families suggested that reminders in general were useful. 
It may therefore be useful to experiment with multiple approaches for reminding 
patients and then use the approach that elicits the most consistent response for 
individual families.  
5. Reflecting on patient health as a part of daily/weekly routines - The health 
tracking dashboard was frequently used by caregivers, less so by patients. It appears 
from the EpiSense app usage logs that caregivers used the app at particular times of 
the day or on particular days of the week such as the weekend. It may, therefore, be 
helpful to ask participants to input a prefered schedule in advance or predict this 
schedule automatically based on weekly routines. 
6. Respecting patient and caregiver privacy - It is also important to respect patient 
and caregiver privacy. A central goal of self-management is for patients to become 
self-sufficient at managing epilepsy. Interventions should be evaluated to ensure that 
patients feel more empowered and independent, not less. In study #3, patients 
expressed that they would be comfortable with having a caregiver review video of 
them, but were often expressed discomfort with reviewing seizure videos. It may be 
safest to design support services for use in the home as opposed to a public setting.  
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7.3 Evaluating Patient Engagement 
The third set of design implications focused on the extent that mobile and wearable 
devices and incentives can improve patient engagement. Overall patients and caregivers 
from our studies were generally eager to try new technologies and consider new 
technology applications, seeing such services as opportunities to improve their quality of 
life. In addition, initial result from study #5, show that the motivational strategies that we 
explored increased patient engagement. I would, therefore, recommend patient goal 




CHAPTER 8. CONCLUSIONS 
Epilepsy self-management practices are essential for effective epilepsy treatment yet 
patients and caregivers often cannot complete these tasks due to a range of logistical, 
social and epilepsy-specific challenges.  
My colleagues and I investigated the feasibility and effectiveness of mobile and wearable 
technologies for supporting daily epilepsy self-reporting and self-management among a 
diverse group of adult and pediatric patients with epilepsy.  
My subsequent research results have identified a range of clinical information needs 
during epilepsy treatment and highlighted several approaches for addressing them. 
● Seizure detection wristbands and a follow-up video review process can provide more 
accurate patient seizure reporting during treatment by reducing false alarms.  
● Daily patient and caregiver surveys can provide clinicians with additional types of 
health data that are important to have during treatment such as medication intake, 
sleep, mood and exercise.  
● Goal setting and daily financial incentives can increase patient and caregiver 
engagement for some, at least during an initial phase of data collection.  
The remainder of this section summarizes key findings related to the following three 
research needs: 
8.1 Establishing Data Collection Needs 
The most pressing clinical data collection need among clinicians was accurate seizure 
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counts. It’s critical that patients and caregivers maintain accurate records of seizures 
between appointments yet studies have shown that patients often struggle with this task 
and are typically unable to report seizures at night. In addition, behaviors such as daily 
medication intake, sleep, exercise and mood are also important seizure precipitates yet 
typically not available. 
My colleagues and I also gained valuable insights regarding data collection practices and 
privacy preferences. In study #4 patients reported that they would be comfortable having 
a caregiver review video of possible seizure events in bed. In study #5 patients similarly 
reported that they would not mind having a caregiver and clinician review the data that 
they collected. In each case, I observed patient safety and independence may outweigh 
certain privacy concerns.  
It is therefore essential to consider these factors when evaluating how computing may be 
able to support patient and caregiver data collection. 
8.2 Improving Data Quality 
EMA is a feasible approach for collecting data from patients and caregivers but must be 
designed around routine interactions to be useful and adopted.  
Health tracking can be a collaborative activity between patients and caregivers. Mobile 
Everyday Computing [80] has served as a useful research and design during out studies. 
Interviews with families in studies #3, #4 and #5 highlighted a myriad of different family 
scheduling constraints. In study #5, I intentionally designed for interruptions and flexible 
scheduling. Introducing “contingent” reminders within the “health tracking” and 
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“motivational incentives” conditions better accommodated caregivers with “late” shifts 
and patients with phone use restrictions or events such as after-school basketball practice. 
8.3 Evaluating Patient Engagement 
The “baseline” condition appears to have had a neutral to negative impact on patient 
engagement patient 27’s responses showing a decrease in SEM-CD and PAM scores.  
No exit surveys for evaluating SEM-CD and PAM among patients in the “health track 
dashboard” condition.  
“Motivational strategies” had a positive impact on patient engagement. Many patients 
checked on daily goal attainment multiple times per day. Initial results based on patient 




CHAPTER 9. CONTRIBUTIONS 
My research has contributed to the fields of HCI and health informatics by addressing 
long-standing gaps within the literature and laying the groundwork to develop future 
tools for supporting pediatric and adult epilepsy treatment and patient self-management. 
In study #5, I designed and evaluated a mobile data collection application based on 
clinical self-reporting needs that I identified from studies #1 and #2, and family self-
management needs that I identified from studies #3 and #5. For example, daily surveys 
prioritized information that clinicians reported needing most during studies #1 and #2 
(e.g. seizure counts, medication adherence, sleep, mood, and exercise).  
My key contributions include: 
1. Establishing data collection needs during epilepsy treatment and investigating the 
extent that current technologies may be suitable for addressing these needs, 
2. Investigating new methods and strategies for improving data collection quality 
as well as identifying the need to improve specific aspects of data collection quality, 
3. Evaluating data collection utility from the perspective of improving patient 
engagement with respect to patient self-efficacy and activation scores. 
Table 22 describes the main results of each of my studies as a first step for addressing 
each of the three respective epilepsy self-management needs that I identified.  
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● Improved the state of knowledge regarding self-management data 
collection needs by: 
○ Establishing clinical self-reporting data collection needs 
 
● Established design insights for mobile/wearable self-management tools by: 
○ Reported the extent that current devices address these needs 
○ Reported the extent that patients/caregivers can use these devices 
○ Reported patient/caregiver preferences with respect to mobile EMA 
and active/passive data collection 
#2 Improving data 
collection 
quality 
● Improved the state of knowledge regarding data collection quality by 
indicating when and where mobile/wearable interventions might further 
improve upon mobile EMA outcomes. 
○ Showed that Empatica E4 seizure detection wristbands can improve 
“seizure count” data quality relative to patient self-reporting at 
night 
○ Showed that a patient and caregiver video review of E4 wristband 
detected seizure events can improve “seizure count” data quality 
 
● My studies also: 
○ Evaluated patient and caregiver consistency, promptness, and 
reliability when collecting data using mobile EMA surveys 
○ Showed that a clinical audience may increase mobile EMA 
adherence and reliability 
○ Showed that a health tracker may increase mobile EMA adherence 
and reliability 
○ Showed that goal setting and rewards further may increase 
adherence and reliability 






● Evaluated the impact of these data collection on patient health scores.  
○ Reported the impact of these tools on patient self-efficacy [185]. 
 
● My studies have shown that, for some families, motivational strategies such 
as goal setting & financial incentives may increase patient engagement 
More broadly, my findings serve to guide the development of future, family focused, 
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mobile and wearable epilepsy self-reporting and management tools.  
In Chapter 7, I presented a set of design implications for supporting both clinical 
treatment and daily self-management among patients, caregivers and clinicians as an 
important step for ensuring that patients make a successful transition between pediatric to 




CHAPTER 10. FUTURE DIRECTIONS 
I recently accepted a postdoc position at the Boston Children’s Hospital (BCH).  
I am excited to continue our research in the area of pediatric epilepsy treatment. I will be 
working with a team to develop seizure detection devices and self-management tools. 
10.1 Establishing data collection needs 
10.1.1 Sustained passive sensing 
It is important to be able to reflect back on patient health information prior to a seizure 
event. The challenge is that people tend to be less motivated to collect patient information 
in the absence seizures or when health information doesn’t appear to change over time. 
Most families are asked to report patient seizures during routine appointments. Newly 
diagnosed patients and patient caregivers tend to collect detailed patient health 
information for the first few months following diagnosis but then gradually collect less 
detailed information over time. For example, one mother showed us a spreadsheet that 
diligently tracked of her daughter’s daily medication intake, sleep, diet, mood and 
menstrual periods for two months following diagnosis but tapered off by the third month. 
Similarly, a father showed us his entries from a SeizureTracker app that he used for 
documenting his daughter’s seizures. He initially documented his daughter’s medication, 
postictal symptoms and seizure type but later only reported seizure onset time and 
duration as the other information did not change.   
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“Motivational strategies” and passive health tracking devices from study #5 may be 
helpful for enabling families to monitor for sudden changes in patient health without 
having to manually collect as much information. For example, an intervention could 
include financial incentives that encourage patients and caregivers to gradually scale up 
daily self-reporting to include additional types of patient health information beyond 
seizure counts such as medication intake, sleep, exercise and mood. This more detailed 
information could then serve as an initial baseline of typical patient behaviors. Health 
tracking devices could then be used to identify significant changes from this baseline 
without additional patient or caregiver reporting.  
10.1.2 Informing Treatment 
Healthcare costs are increasing. New forms of patient outreach could help to address 
aspects of these challenges. I recently worked with a team of undergraduates at Georgia 
Tech and a nurse practitioner at CHOA to develop a clinician dashboard as described in 
Chapter 6. More work is needed. For example, existing electronic health records (EHR) 
are poorly suited for showing temporal relationships between medication intake and 
behavioral factors that can impact seizure control as shown in Figure 2.  
It may therefore be beneficial to investigate these types of workflows and relationships 
further for supporting clinical practice. 
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Figure 2 - Examining temporal relations between medication and seizure control 
10.2 Improving data collection quality 
Existing seizure detection devices do not detect non-convulsive seizures. It would be 
helpful to support a broader range of seizure types.  In my research, I looked into the 
feasibility of additional types of sensing. Environmental sensors tends to be less intrusive 
but provide a poorer signal while patient worn devices tend to be more intrusive with the 
benefit of a better signal as shown in Figure 3. EEG headbands with soft conductive 
thread and higher resolution pressure sensing mattress pads can likely detect more subtle 
seizures and limb movements that likely would not have been detected during previous 
studies. In both cases, my proposed video review approach from study #2 could help to 




Figure 3 - Non-convulsive seizure detection and sensing considerations 
10.3 Evaluating patient engagement 
10.3.1 Transition Readiness 
Improved metrics for predicting transition readiness. “Transition of care” is an important 
component of pediatric epilepsy treatment. The Transitional Readiness Assessment 
Questionnaire (TRAQ) and PAM are each useful instruments for assessing a patient’s 
knowledge and skills prior to adult care but require patients to complete lengthy surveys. 
Health tracking and other forms of passive data collection could play a role in developing 
new types of transition metrics that make similar predictions but with much less data 
collection burden on the parts of patients and caregivers. For example, in the future, we 
could investigate whether reduced variability among patient and caregiver self-reports 
correlates with increased readiness for transition as shown in Figure 4. 
 









12. APPENDIX B. SURVEY INSTRUMENTS 
12.1 EpiSense Surveys 
12.1.1 Patient 
12.1.1.1 Morning 
1. What time did you go bed? 
__________________________________ 
2. What time did you wake up? 
__________________________________ 
3. Did you take all of your medicine yesterday? 
Yes No 
4. How are you feeling this morning?  
_________________________________ 
Sad  Neutral   Happy 
(Place a mark on the scale above) 
5. Did you have any seizures yesterday? 
Yes No 
6. Were you physically active for a total of at least 60 minutes yesterday? (Add up 
all the time you spent in any kind of physical activity that increased your heart 
rate and made you breathe hard some of the time) 
Yes No 
7. Are you at home? school? or somewhere else? (we're wondering whether people 
tend to answer questions at home or school each day) 
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Home School Somewhere else 
12.1.12 Weekly 
1. Did you have any seizures this week? 
Yes No 
2. Did any of the seizures last longer than 5 minutes? 
Yes No 
3. Did you take all your medicine this week? 
Yes No 
4. In the past 7 days I felt nervous 
Never Almost Never Sometimes Often Almost Always 
5. In the past 7 days I felt scared 
Never Almost Never Sometimes Often Almost Always 
6. In the past 7 days I felt worried 
Never Almost Never Sometimes Often Almost Always 
7. In the past 7 days... I go to bed and wake up at about the same time every day 
_________________________________ 
Never      Always 
(Place a mark on the scale above) 
8. On an average school day this week... How many hours did you play video or 
computer games or use a computer for something that was not school work per 
day this week? ((Count time spent on things such as Xbox, PlayStation, an iPod, 
an iPad or other tablet, a smartphone, YouTube, Facebook or other social 
networking tools, and the Internet.)) 
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I do not play video or computer games or use a computer for something that is not 
school work Less than 1 hour per day 1 hour per day 2 hours per day 3 hours per 
day 4 hours per day 5 or more hours per day 
9. On an average school day this week... How many hours did you watch TV? 
I do not watch TV on an average school day Less than 1 hour per day 1 hour per 
day 2 hours per day 3 hours per day 4 hours per day 5 or more hours per day 
10. During the past 7 days, on how many days were you physically active for a total 
of at least 60 minutes per day? 
_________ (Add up all the time you spent in any kind of physical activity that 
increased your heart rate and made you breathe hard some of the time.) 
12.1.1.3 Intake 
1. I keep track of how often I have seizures. 
None of the time A few times Some of the time Most of the time All of the time 
2. I keep track of when my seizures occur. 
None of the time A few times Some of the time Most of the time All of the time 
3. I keep a record of the types of seizures I have. 
None of the time A few times Some of the time Most of the time All of the time 
4. I record my seizures with… 
an online tracker/diary a paper log/diary an alternate method that is not listed here 
5. Please describe any alternate seizure tracking methods that you use 
__________________________________________ 




7. How SEVERE (INTENSE) were your seizures overall? 
_________________________________ 
Very  Mild Moderate  Very Severe 
(Place a mark on the scale above) 
8. I take my seizure medicine at about the same time each day. 
None of the time A few times Some of the time Most of the time All of the time 
9. I do things that I enjoy to help manage stress. 
None of the time A few times Some of the time Most of the time All of the time 
10. I use some techniques (such as relaxation, guided imagery, and self-hypnosis) to 
manage stress. 
None of the time A few times Some of the time Most of the time All of the time 
11. In the past 30 days I worry that something bad will happen to me 
Never Sometimes Often Always 
12. I go to bed and wake up at about the same time every day 
None of the time A few times Some of the time Most of the time All of the time 
13. In the past 30 days I exercise at least half an hour most days of the week 
None of the time A few times Some of the time Most of the time All of the time 
14. Would you say that in general your health is -? 
Excellent Very Good Good Fair Poor 
15. Do you have any difficulties with memory? 
Yes No 
16. How confident do you feel that you can keep any other symptoms or health 




not at all confident    totally confident 
(Place a mark on the scale above) 
17. How confident do you feel that you can the different tasks and activities needed to 
manage your health not at all condition so as to reduce your need to see a doctor? 
_________________________________ 
not at all confident    totally confident 
18. How confident do you feel that you can do things other than just taking 
medication to reduce how much not at all your illness affects your everyday life? 
_________________________________ 
not at all confident    totally confident 
19. What other CHOA projects are you involved in? 
__________________________________________ 
20. When all is said and done, I am the person who is responsible for managing my 
health condition (PAM Q1) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
21. Taking an active role in my own health care is the most important factor in 
determining my health and ability to function (PAM Q2) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
22. I am confident that I can take actions that will help prevent or minimize some 
symptoms or problems associated with my health condition (PAM Q3) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
23. I know what each of my prescribed medications do (PAM Q4) 
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Disagree Strongly Disagree Agree Agree Strongly N/A 
24. I am confident that I can tell when I need to go get medical care and when I can 
handle a health problem myself (PAM Q5) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
25. I am confident I can tell my health care provider concerns I have even when he or 
she does not ask (PAM Q6) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
26. I am confident that I can follow through on medical treatments I need to do at 
home (PAM Q7) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
27. I understand the nature and causes of my health condition(s) (PAM Q8) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
28. I know the different medical treatment options available for my health condition 
(PAM Q9) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
29. I have been able to maintain the lifestyle changes for my health that I have made 
(PAM Q10) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
30. I know how to prevent further problems with my health condition (PAM Q11) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
31. I am confident I can figure out solutions when new situations or problems arise 
with my health condition (PAM Q12) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
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32. I am confident that I can maintain lifestyle changes like diet and exercise even 
during times of stress (PAM Q13) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
12.1.1.4 Exit 
1. I keep track of how often I have seizures. 
None of the time A few times Some of the time Most of the time All of the time 
2. I keep track of when my seizures occur. 
None of the time A few times Some of the time Most of the time All of the time 
3. I keep a record of the types of seizures I have. 
None of the time A few times Some of the time Most of the time All of the time 
4. I record my seizures with… 
an online tracker/diary a paper log/diary an alternate method that is not listed here 
5. Please describe any alternate seizure tracking methods that you use 
_________________________________ 
6. Have any seizures occurred in the last 30 days? 
Yes No 
7. How SEVERE (INTENSE) were your seizures overall? 
_________________________________ 
Very   Mild Moderate  Very Severe 
(Place a mark on the scale above) 
8. I take my seizure medicine at about the same time each day. 
None of the time A few times Some of the time Most of the time All of the time 
9. I do things that I enjoy to help manage stress. 
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None of the time A few times Some of the time Most of the time All of the time 
10. I use some techniques (such as relaxation, guided imagery, and self-hypnosis) to 
manage stress. 
None of the time A few times Some of the time Most of the time All of the time 
11. In the past 30 days I worry that something bad will happen to me 
Never Sometimes Often Always 
12. I go to bed and wake up at about the same time every day 
None of the time A few times Some of the time Most of the time All of the time 
13. In the past 30 days I exercise at least half an hour most days of the week 
None of the time A few times Some of the time Most of the time All of the time 
14. Would you say that in general your health is -? 
Excellent Very Good Good Fair Poor 
15. How confident do you feel that you can keep any other symptoms or health 
problems you have from not at all interfering with the things you want to do?  
_________________________________ 
not at all confident    totally confident 
(Place a mark on the scale above) 
16. How confident do you feel that you can the different tasks and activities needed to 
manage your health not at all condition so as to reduce your need to see a doctor? 
_________________________________ 
not at all confident    totally confident 
17. How confident do you feel that you can do things other than just taking 




not at all confident    totally confident 
18. What other CHOA projects are you involved in? 
__________________________________________ 
19. When all is said and done, I am the person who is responsible for managing my 
health condition (PAM Q1) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
20. Taking an active role in my own health care is the most important factor in 
determining my health and ability to function (PAM Q2) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
21. I am confident that I can take actions that will help prevent or minimize some 
symptoms or problems associated with my health condition (PAM Q3) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
22. I know what each of my prescribed medications do (PAM Q4) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
23. I am confident that I can tell when I need to go get medical care and when I can 
handle a health problem myself (PAM Q5) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
24. I am confident I can tell my health care provider concerns I have even when he or 
she does not ask (PAM Q6) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
25. I am confident that I can follow through on medical treatments I need to do at 
home (PAM Q7) 
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Disagree Strongly Disagree Agree Agree Strongly N/A 
26. I understand the nature and causes of my health condition(s) (PAM Q8) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
27. I know the different medical treatment options available for my health condition 
(PAM Q9) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
28. I have been able to maintain the lifestyle changes for my health that I have made 
(PAM Q10) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
29. I know how to prevent further problems with my health condition (PAM Q11) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
30. I am confident I can figure out solutions when new situations or problems arise 
with my health condition (PAM Q12) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
31. I am confident that I can maintain lifestyle changes like diet and exercise even 
during times of stress (PAM Q13) 
Disagree Strongly Disagree Agree Agree Strongly N/A 
Please rate the level that you agree with the following statements from 1-strongly 
disagree to strongly agree. 
32. The online daily logs/diaries helped me to better understand the behaviors related 
to epilepsy for me. 
1. strongly disagree 2. disagree 3. somewhat disagree 4. neither agree or 5. 
disagree 6. somewhat agree 7. agree 8. strongly agree 
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33. I am glad that I participated in this study. 
1. strongly disagree 2. disagree 3. somewhat disagree 4. neither agree or 5. 
disagree 6. somewhat agree 7. agree 8. strongly agree 
34. I would recommend online daily logs/diaries on behaviors related to epilepsy to 
other families. 
1. strongly disagree 2. disagree 3. somewhat disagree 4. neither agree or 5. 
disagree 6. somewhat agree 7. agree 8. strongly agree 
12.1.1.5 Seizure 
1. What time did the seizure start? 
__________________________________ 
2. How long did the seizure last? (minutes) 
< 1 1 2 3 4 5 >5 
12.1.2 Caregiver 
12.1.2.1 Morning 
1. What time did your child go bed? 
__________________________________ 
2. What time did your child wake up? 
__________________________________ 
3. Did your child take all of his or her medicine yesterday? 
Yes No 




5. 5 Did your child have any seizures yesterday? 
Yes No 
6. Was your child physically active for a total of at least 60 minutes yesterday?  
(Add up all the time that he or she spent in any kind of physical activity that 
increased his or her heart rate and made it hard for him or her breathe hard some 
of the time) 
Yes No 
7. Are you at home? work? or somewhere else? (we're Home wondering whether 
people tend to answer questions at Work home or school each day)  
Home, Work, Somewhere else 
12.1.2.2 Weekly 
1. Did your child have any seizures this week? 
Yes No 
2. Did any of the seizures last longer than 5 minutes? 
Yes No 
3. Did your child take all of his or her medicine this week? 
Yes No 
4. In the past 7 days, my child felt nervous 
Never Almost Never Sometimes Often Almost Always 
5. In the past 7 days, my child felt scared 
Never Almost Never Sometimes Often Almost Always 
6. In the past 7 days, my child felt worried 
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Never Almost Never Sometimes Often Almost Always 
7. In the past 7 days, my child goes to bed at the same time at night 
Never Almost Never Sometimes Often Almost Always 
8. On an average school day this week... How many hours did your child play video 
or computer games or use a computer for something that was not school work per 
day? ((Count time spent on things such as Xbox, PlayStation, an iPod, an iPad or 
other tablet, a smartphone, YouTube, Facebook or other social networking tools, 
and the Internet.)) 
I do not play video or computer games or use a computer for something that is not 
school work Less than 1 hour per day 1 hour per day 2 hours per day 3 hours per 
day 4 hours per day 5 or more hours per day 
9. On an average school day this week... How many hours did your child watch TV? 
I do not watch TV on an average school day Less than 1 hour per day 1 hour per 
day 2 hours per day 3 hours per day 4 hours per day 5 or more hours per day 
10. During the past 7 days, on how many days was your child physically active for a 
total of at least 60 minutes per day? 
__________________________________  
(Add up all the time you spent in any kind of physical activity that increased your 
heart rate and made you breathe hard some of the time.)  
12.1.2.3 Intake 
1. How many months since your child's diagnosis? 
__________________________________ 




3. How many days has it been since your child's most recent seizure? 
__________________________________ (It's ok to give an approximate answer) 
4. Has your child had any seizures in the last 30 days? 
Yes No 
5. What types of seizure (s) does your child have? 
6. I keep track of how often my child has seizures. 
None of the time A few times Some of the time Most of the time All of the time 
7. I keep track of when my child's seizures occur. 
None of the time A few times Some of the time Most of the time All of the time 
8. I keep a record of the types of seizures that my child has. 
None of the time A few times Some of the time Most of the time All of the time 
9. I record my child's seizures with… 
an online tracker/diary a paper log/diary an alternate method that is not listed here 
10. Please describe any alternate seizure tracking methods that you use 
11. Please describe any pre-seizure symptoms. 
12. Please describe any post-seizure symptoms. 
13. How SEVERE (INTENSE) were your child's seizures overall in the past 4 weeks? 
_________________________________ 
Very   Mild Moderate  Very Severe 
(Place a mark on the scale above) 
14. In the past 30 days my child felt like something awful might happen. 
Never Sometimes Often Always 
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15. How often would you say that your child's sleep quality varies from week to 
week? 
seldom some often 
16. In the past 30 days my child exercises at least half an hour most days of the week. 
None of the time A few times Some of the time Most of the time All of the time 
17. Which health care provider(s) do you see for treatment of your child's 
seizures/epilepsy? Please select all that apply. 
Primary care provider General neurologist Epileptologist (neurologist who 
specializes in epilepsy) Other epilepsy specialists (advanced practice nurse, 
neurosurgeon, psychiatrist) Mental health professional None 
18. How old is your child? (years) 
__________________________________ 
19. What's your child's gender? 
male female other 
20. What's your child's race? 
White Black Asian/Pacific Islander American Indian Other 
21. Would you say that in general your child's health is -? 
Excellent Very Good Good Fair Poor 
22. Does your child have any difficulties with memory? 
Yes No 
23. What's your child's highest level of education? 
None elementary high-school/GED some college college college degree or higher 
The following questions are about you: 
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24. What's your gender? 
male female other 
25. What's your race? 
White Black Asian/Pacific Islander American Indian Other 
26. What's your annual household income? (select range) 
Less than $25,000 $25,000 to $49,999 $50,000 to $74,999 $75,000 to $99,999 
$100,000 to $124,999 $125,000 to $149,999 $150,000 or more 
27. How would you describe your neighborhood? 
rural urban suburban none of the above or not sure 
28. What's your highest level of education? 
None elementary high-school/GED some college college college degree or higher 
29. Has your child ever been held back a grade in school?  
Yes No 
30. What is your employment status? 
full time part time unemployed 
31. Do you have any work limitations? (e.g. quit job) 
32. Do you stay at home full-time as a caregiver? 
Yes No 
33. If so how many years have you lived at home? 
__________________________________ 





1. I keep track of how often my child has seizures. 
None of the time A few times Some of the time Most of the time All of the time 
2. I keep track of when my child's seizures occur. 
None of the time A few times Some of the time Most of the time All of the time 
3. I keep a record of the types of seizures my child has. 
None of the time A few times Some of the time Most of the time All of the time 
4. Have any seizures occurred in the last 30 days? 
Yes No 
5. Please describe any pre seizure symptoms. 
6. Please describe any post seizure symptoms. 
7. How SEVERE (INTENSE) were your child's seizures overall in the past 4 weeks? 
__________________________________ 
Very   Mild Moderate  Very Severe 
(Place a mark on the scale above) 
8. Please rate the level that you agree with the following statements regarding your 
child's epilepsy treatment. 
None of the time A few times Some of the time Most of the time All of the time  
9. My child takes his or her seizure medicine at about the same time each day. 
10. My child does things that he or she enjoys to help manage stress.  
My child uses techniques (such as relaxation, guided imagery, and self-hypnosis) 
to manage stress. 
11. In the past 30 days my child worries that something bad will happen to him or her 
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12. My child goes to bed and wakes up at about the same time every day 
13. In the past 30 days my child exercises at least half an hour most days of the week 
Please rate the level that you agree with the following statements regarding the usability 
of the mobile app. 
14. Did you have difficulty reading the words on your phone screen? Could you 
conveniently answer the survey questions on the phone? 
no/not at all somewhat very extremely  
15. Were the instructions clear to you? 
no/not at all somewhat very extremely  
16. Was your participation in this study burdensome? 
no/not at all somewhat very extremely  
17. How often did you fill in the surveys directly after the first prompt? 
in less than 50% of the time in approximately 50% of the time in approximately 
75% of the time in almost all the times 
18. How can we improve the data collection? For example - How could we make the 
surveys easier? Are there additional aspects of your daily life that you think 
would helpful to keep track in the future? 
Please rate the level that you agree with the following statements regarding your 
experience with data collection. 
19. The online daily logs/diaries helped me to better understand behaviors related to 
my child's epilepsy. 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
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somewhat agree, agree, strongly agree 
20. I am glad that I participated in this study. 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
somewhat agree, agree, strongly agree 
21. I would recommend online daily logs/diaries on behaviors related to epilepsy to 
other families. 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
somewhat agree, agree, strongly agree 
22. The questions in the dairies/logs helped me to better understand self care related 
to my child's epilepsy. 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
somewhat agree, agree, strongly agree 
23. I will keep notes or monitor seizure using a paper or online diary 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
somewhat agree, agree, strongly agree 
24. I will keep notes or monitor other aspects of your daily life such as sleep, 
exercise, screen time, etc. 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
somewhat agree, agree, strongly agree 
25. Please comment on how the study help you to "better understand behaviors 
related to your child's epilepsy". 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
somewhat agree, agree, strongly agree 
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26. Please describe any other ways that you may have benefited from participating in 
the study in other ways beyond better understanding behaviors related to your 
child's epilepsy? 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
somewhat agree, agree, strongly agree 
Please rate the level that you agree with the following statements regarding your overall 
experience as a caregiver. 
27. I believe I am more knowledgeable as a caregiver after this study. 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
somewhat agree, agree, strongly agree 
28. I learned useful caregiving strategies from the study. 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
somewhat agree, agree, strongly agree 
29. I feel more confident as a caregiver after participating in the data collection. 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
somewhat agree, agree, strongly agree 
30. I feel I have more caregiving skills after participating in the study. 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
somewhat agree, agree, strongly agree 
31. The study was relevant to caregiving. 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
somewhat agree, agree, strongly agree 
32. How did you feel when you had to note your child's seizures and activity such as 
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sleep and exercise every day twice a day? 
strongly disagree, disagree, somewhat disagree, neither agree or disagree, 
somewhat agree, agree, strongly agree 
Please give any comments about the act of noting different aspects of your child's daily 
living with seizures (e.g., seizures, medication taking, sleep, etc.) that you want to share. 
33. Would you like additional information on taking care of your children with 
epilepsy? 
Yes No 
34. What types of information would be useful? Please select all that apply. 
Medication adherence Self-reporting seizures and lifestyle factors that can impact 
the likelihood of seizures (e.g. sleep, diet) Tips for managing epilepsy and 
communicating epilepsy related needs to others during everyday life Other - I'd 
like additional information about something else 
Please describe any additional information that you think may be helpful for 
taking care of your child with epilepsy.  
35. What methods would you prefer for education about these topics? Please select all 
that apply. 
workshop series of workshops web-based course mobile/tablet course mix of 
these methods other 
36. Please describe any other methods that you would prefer for education about these 
topics. 
37. Have you talked to your child about their ability to take care of their health when 




38. What topics have you discussed? Please check all that applies. 
Making appointments How to prepare for appointments Talking to their doctor 
My child's medicines How to refill medicines Epilepsy triggers and symptoms 
Disclosing to my epilepsy/seizure disorder to others Seizure safety How to get 
support from others General wellness (e.g. exercise and eating healthy) Coping 
with illness and stress Other 
39. Please describe any other topics that you have discussed. 
12.1.2.5 Seizure 
1. What time did the seizure start? 
__________________________________ 
2. How long did the seizure last? (minutes) 
< 1 1 2 3 4 5 >5 
12.3 Reference Surveys 
12.3.1 Self-Efficacy for Managing Chronic Disease 6-item Scale (SEM-CD) 
1. How confident do you feel that you can keep the fatigue caused by your disease 
from interfering with the things you want to do? 
_________________________________ 
Not at all confident  Totally confident 
2. How confident do you feel that you can keep the physical discomfort or pain of 




Not at all confident  Totally confident 
3. How confident do you feel that you can keep the emotional distress caused by 
your disease from interfering with the things you want to do? 
_________________________________ 
Not at all confident  Totally confident 
4. How confident do you feel that you can keep any other symptoms or health 
problems you have from interfering with the things you want to do? 
_________________________________ 
Not at all confident  Totally confident 
5. How confident do you feel that you can the different tasks and activities needed to 
manage your health condition so as to reduce your need to see a doctor? 
_________________________________ 
Not at all confident  Totally confident 
6. How confident do you feel that you can do things other than just taking 
medication to reduce how much your illness affects your everyday life? 
_________________________________ 
Not at all confident  Totally confident 
12.3.2 Patient Activation Measure (PAM) 
1. When all is said and done, I am the person who is responsible for managing my 
health condition 
2. Taking an active role in my own health care is the most important factor in 
determining my health and ability to function  
 
148 
3. I am confident that I can take actions that will help prevent or minimize some 
symptoms or problems associated with my health condition 
4. I know what each of my prescribed medications do 
5. I am confident that I can tell when I need to go get medical care and when I can 
handle a health problem myself 
6. I am confident I can tell my health-care provider concerns I have even when he or 
she does not ask 
7. I am confident that I can follow through on medical treatments I need to do at 
home 
8. I understand the nature and causes of my health condition(s) 
9. I know the different medical treatment options available for my health condition 
10. I have been able to maintain the lifestyle changes for my health that I have made 
11. I know how to prevent further problems with my health condition 
12. I am confident I can figure out solutions when new situations or problems arise 
with my health condition 
13. I am confident that I can maintain lifestyle changes like diet and exercise even 




13. APPENDIX C. SELF-REPORTING METRICS 
13.1 Self-reporting consistency 
(Top) All participants (Bottom) participants who reported on eight or more study dates. 





13.2 Self-reporting promptness 
The promptness of self-reporting, computed as the average latency and standard deviation 





13.3 Self-reporting reliability 
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